[{"internal_id": 128942136, "Award ID": "2020PMBX0017", "Award Amount": 1669261.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "BJA FY 20 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b3e32144-65b9-3c63-e683-7ab9082cc57c-C", "generated_internal_id": "ASST_NON_2020PMBX0017_1550"}, {"internal_id": 128941856, "Award ID": "2020PMBX0016", "Award Amount": 1999998.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "AUTOMATION AND INTEGRATION OF UTAH'S PDMP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ad190718-78aa-6598-2e74-432b73a2d3f5-C", "generated_internal_id": "ASST_NON_2020PMBX0016_1550"}, {"internal_id": 128941591, "Award ID": "2020PMBX0015", "Award Amount": 1945652.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "WI EPDMP HOLISTIC UPGRADE PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_2020PMBX0015_1550"}, {"internal_id": 128942110, "Award ID": "2020PMBX0014", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "63be0e77-930e-4b89-e9e3-610349642b13-C", "generated_internal_id": "ASST_NON_2020PMBX0014_1550"}, {"internal_id": 128941749, "Award ID": "2020PMBX0013", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "ILLINOIS 2020 PDMP IMPLEMENTATION AND ENHANCEMENT PROJECTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76cf737b-6066-d86b-2865-0295d98359df-C", "generated_internal_id": "ASST_NON_2020PMBX0013_1550"}, {"internal_id": 128941172, "Award ID": "2020PMBX0012", "Award Amount": 1298502.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "KENTUCKY ALL SCHEDULE PRESCRIPTION ELECTRONIC REPORTING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_2020PMBX0012_1550"}, {"internal_id": 128941349, "Award ID": "2020PMBX0011", "Award Amount": 975489.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "KANSAS BOARD OF PHARMACY 2020 PDMP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bf25f4c8-865f-2541-885c-7cb500bdfac4-C", "generated_internal_id": "ASST_NON_2020PMBX0011_1550"}, {"internal_id": 128942046, "Award ID": "2020PMBX0010", "Award Amount": 781761.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "BJA FY 20 NEVADA PRESCRIPTION MONITORING PROGRAM ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f181d4c2-1fa0-1f32-a106-d3700bad68a3-C", "generated_internal_id": "ASST_NON_2020PMBX0010_1550"}, {"internal_id": 128942267, "Award ID": "2020PMBX0009", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "PUERTO RICO HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ccec1439-4fc7-aa7b-66d5-8ed9ab9f57bb-C", "generated_internal_id": "ASST_NON_2020PMBX0009_1550"}, {"internal_id": 131699952, "Award ID": "2020PMBX0008", "Award Amount": 1865325.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "CT PMP HAROLD ROGERS GRANT FY 20", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9f5ab5d3-ee3f-0b37-4bb5-b69a20c9c0a4-C", "generated_internal_id": "ASST_NON_2020PMBX0008_1550"}, {"internal_id": 128941988, "Award ID": "2020PMBX0007", "Award Amount": 1369670.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "ARKANSAS FY2020 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f67c91cf-d824-5d22-67e1-a6ce7f3be1eb-C", "generated_internal_id": "ASST_NON_2020PMBX0007_1550"}, {"internal_id": 131699947, "Award ID": "2020PMBX0006", "Award Amount": 2000000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2020PMBX0006_1550"}, {"internal_id": 145384000, "Award ID": "2020PMBX0005", "Award Amount": 1930382.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "OPTIMIZING MARYLAND'S PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3c30f51b-0198-c278-4848-50104ea4824f-C", "generated_internal_id": "ASST_NON_2020PMBX0005_1550"}, {"internal_id": 128941846, "Award ID": "2020PMBX0004", "Award Amount": 1013858.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "FY 20 ALASKA PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "da787dd9-e8ac-c70e-7520-73e79c96154a-C", "generated_internal_id": "ASST_NON_2020PMBX0004_1550"}, {"internal_id": 131699770, "Award ID": "2020PMBX0003", "Award Amount": 1896338.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "PENNSYLVANIA PDMP SYSTEM ENHANCEMENT INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f883d24-5b22-bdcc-2a80-1fe9d0f8356b-C", "generated_internal_id": "ASST_NON_2020PMBX0003_1550"}, {"internal_id": 128941081, "Award ID": "2020PMBX0002", "Award Amount": 1376350.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "OHIO OARRS FY 2020 DATA ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2020PMBX0002_1550"}, {"internal_id": 131699991, "Award ID": "2020PMBX0001", "Award Amount": 1979031.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-10-22", "CFDA Number": "16.754", "Description": "IMPROVING THE MA PMP THROUGH TECHNOLOGY-BASED ENHANCEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9aef8afa-daa8-fb14-4a71-e9df3274b79d-C", "generated_internal_id": "ASST_NON_2020PMBX0001_1550"}, {"internal_id": 86627182, "Award ID": "2019PMBX0023", "Award Amount": 722137.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-27", "CFDA Number": "16.754", "Description": "STATE OF NEW HAMPSHIRE 2019 PDMP PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "70829962-0377-1b84-37cb-4ced6a0d88e7-C", "generated_internal_id": "ASST_NON_2019PMBX0023_1550"}, {"internal_id": 86627181, "Award ID": "2019PMBX0017", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-27", "CFDA Number": "16.754", "Description": "OKLAHOMA STATE BUREAU OF NARCOTICS AND DANGEROUS DRUG CONTROL PMP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0f7f672e-1cc8-1e61-1451-a9cb548d3a6e-C", "generated_internal_id": "ASST_NON_2019PMBX0017_1550"}, {"internal_id": 86627180, "Award ID": "2019PMBX0016", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "ILLINOIS 2019 PRESCRIPTION MONITORING PROGRAM ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76cf737b-6066-d86b-2865-0295d98359df-C", "generated_internal_id": "ASST_NON_2019PMBX0016_1550"}, {"internal_id": 86627179, "Award ID": "2019PMBX0015", "Award Amount": 1932830.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "NORTH CAROLINA CONTROLLED SUBSTANCES REPORTING SYSTEM IMPROVEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "44c05f0e-2559-a608-5a78-7cedb80b5c53-C", "generated_internal_id": "ASST_NON_2019PMBX0015_1550"}, {"internal_id": 86627178, "Award ID": "2019PMBX0014", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-25", "CFDA Number": "16.754", "Description": "FY2019 COMPREHENSIVE OPIOID ABUSE SITE-BASED PROGRAM; CATEGORY 3", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2019PMBX0014_1550"}, {"internal_id": 86627177, "Award ID": "2019PMBX0013", "Award Amount": 990249.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-25", "CFDA Number": "16.754", "Description": "ENHANCING KASPER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_2019PMBX0013_1550"}, {"internal_id": 86627176, "Award ID": "2019PMBX0012", "Award Amount": 2000000.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "RHODE ISLAND PRESCRIPTION DRUG MONITORING PROGRAM ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f0e17ae4-fc2b-6e41-557e-d243f5bbb5d6-C", "generated_internal_id": "ASST_NON_2019PMBX0012_1550"}, {"internal_id": 86627175, "Award ID": "2019PMBX0011", "Award Amount": 1726497.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "OHIO PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2019PMBX0011_1550"}, {"internal_id": 86627174, "Award ID": "2019PMBX0010", "Award Amount": 1934086.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "ST. LOUIS COUNTY MULTI-JURISDICTIONAL PDMP FOR MISSOURI", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468c78ed-336a-bf68-387a-a257b3eb22a0-C", "generated_internal_id": "ASST_NON_2019PMBX0010_1550"}, {"internal_id": 86627173, "Award ID": "2019PMBX0009", "Award Amount": 1996316.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "WASHINGTON STATE PMP DATA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0dd8db32-c4c1-d3b3-4fe7-79361227c1b1-C", "generated_internal_id": "ASST_NON_2019PMBX0009_1550"}, {"internal_id": 86627172, "Award ID": "2019PMBX0008", "Award Amount": 1058352.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-24", "CFDA Number": "16.754", "Description": "IMPROVE PDMP UTILIZATION AND PATIENT OUTCOMES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "04c91383-4791-7851-87fe-3cebca9b8ce1-C", "generated_internal_id": "ASST_NON_2019PMBX0008_1550"}, {"internal_id": 69842485, "Award ID": "2018PMBXK125", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "COLORADO PUBLIC SAFETY AND PUBLIC HEALTH INFORMATION-SHARING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c744e75b-6c82-8490-fac2-35b735f965e2-C", "generated_internal_id": "ASST_NON_2018PMBXK125_1550"}, {"internal_id": 69842486, "Award ID": "2018PMBXK123", "Award Amount": 978563.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "PUBLIC SAFETY AND PUBLIC HEALTH INFORMATION-SHARING PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a00f6ce0-9288-7075-aa41-f301a22e9a05-C", "generated_internal_id": "ASST_NON_2018PMBXK123_1550"}, {"internal_id": 69842487, "Award ID": "2018PMBXK101", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "STATE OF WISCONSIN FY18 COMPREHENSIVE OPIOID ABUSE SITE-BASED PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "477f4d5f-3f0c-bde9-d560-23291f4a1027-C", "generated_internal_id": "ASST_NON_2018PMBXK101_1550"}, {"internal_id": 69841571, "Award ID": "2018PMBXK098", "Award Amount": 994523.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "FY 18 COAP CATEGORY 6", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0231c66f-0920-a26b-9ab6-73a18fa1d2d2-C", "generated_internal_id": "ASST_NON_2018PMBXK098_1550"}, {"internal_id": 69842488, "Award ID": "2018PMBXK094", "Award Amount": 990552.1, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "360 DEGREE ADDICTION DATABASE PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "105c7ddd-d596-41fb-dbf1-9b1607229618-C", "generated_internal_id": "ASST_NON_2018PMBXK094_1550"}, {"internal_id": 69842489, "Award ID": "2018PMBXK051", "Award Amount": 920712.39, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "ACTION RESEARCH TO REDUCE OPIOID SUPPLY AND DEMAND", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c477975b-68db-c3dc-4a79-b95cb9f6ab3e-C", "generated_internal_id": "ASST_NON_2018PMBXK051_1550"}, {"internal_id": 69842490, "Award ID": "2018PMBXK050", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "COAP CT PRESCRIPTION MONITORING PROGRAM PARTNERSHIP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9f5ab5d3-ee3f-0b37-4bb5-b69a20c9c0a4-C", "generated_internal_id": "ASST_NON_2018PMBXK050_1550"}, {"internal_id": 69841323, "Award ID": "2018PMBXK040", "Award Amount": 935401.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "VENTURA COUNTY OPIOID ABUSE SUPPRESSION TASKFORCE (COAST)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "280b6656-3926-9bce-3c65-b46c663932fb-C", "generated_internal_id": "ASST_NON_2018PMBXK040_1550"}, {"internal_id": 69841578, "Award ID": "2018PMBXK036", "Award Amount": 989219.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "PDMP DATA LINKAGES  DATA VISUALIZATIONS  DATA SHARING ABILITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0dd8db32-c4c1-d3b3-4fe7-79361227c1b1-C", "generated_internal_id": "ASST_NON_2018PMBXK036_1550"}, {"internal_id": 69841852, "Award ID": "2018PMBXK034", "Award Amount": 648221.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "ST. MARY''S COUNTY OPIOID INFORMATION SHARING COLLABORATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3e9e2be1-06e5-8c9b-07a5-9d00cfafa0fb-C", "generated_internal_id": "ASST_NON_2018PMBXK034_1550"}, {"internal_id": 69841556, "Award ID": "2018PMBXK026", "Award Amount": 997891.69, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "INITIATIVE FOR OPTIMIZING PDMP USE AND PREDICTING OPIOID-RELATED HARMS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1e2f11d9-030b-5288-d89f-1f6fd7f111f3-C", "generated_internal_id": "ASST_NON_2018PMBXK026_1550"}, {"internal_id": 69841538, "Award ID": "2018PMBXK021", "Award Amount": 602983.19, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "UTAH'S DRUG MONITORING INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ad190718-78aa-6598-2e74-432b73a2d3f5-C", "generated_internal_id": "ASST_NON_2018PMBXK021_1550"}, {"internal_id": 69841513, "Award ID": "2018PMBX0024", "Award Amount": 0.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "FY18 INDIANA COAP PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bc28df42-3aaa-bfb0-4506-19e2ca6fd36f-C", "generated_internal_id": "ASST_NON_2018PMBX0024_1550"}, {"internal_id": 69842245, "Award ID": "2018PMBX0023", "Award Amount": 365458.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "WISCONSIN EPDMP INTEROPERABILITY ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_2018PMBX0023_1550"}, {"internal_id": 69841455, "Award ID": "2018PMBX0022", "Award Amount": 750000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "NEBRASKA PDMP ENHANCEMENT AND UPDATED TRAINING PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "029201fb-3584-d3e8-463e-e1d59e975a9c-C", "generated_internal_id": "ASST_NON_2018PMBX0022_1550"}, {"internal_id": 69841456, "Award ID": "2018PMBX0021", "Award Amount": 700954.11, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "ENHANCEMENTS TO PMP FOR OPIOID ABUSE AND DIVERSION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0f7f672e-1cc8-1e61-1451-a9cb548d3a6e-C", "generated_internal_id": "ASST_NON_2018PMBX0021_1550"}, {"internal_id": 69841457, "Award ID": "2018PMBX0020", "Award Amount": 0.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "ILLINOIS PRESCRIPTION MONITORING PROJECT - CATEGORY 5", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76cf737b-6066-d86b-2865-0295d98359df-C", "generated_internal_id": "ASST_NON_2018PMBX0020_1550"}, {"internal_id": 69841585, "Award ID": "2018PMBX0019", "Award Amount": 470028.78, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "ENHANCING THE KENTUCKY PRESCRIPTION ELECTRONIC REPORTING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_2018PMBX0019_1550"}, {"internal_id": 69841868, "Award ID": "2018PMBX0018", "Award Amount": 624656.95, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "NEVADA PRESCRIPTION MONITORING PROGRAM ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f181d4c2-1fa0-1f32-a106-d3700bad68a3-C", "generated_internal_id": "ASST_NON_2018PMBX0018_1550"}, {"internal_id": 69841592, "Award ID": "2018PMBX0017", "Award Amount": 0.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "BJA FY 2018 HAROLD ROGERS PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bcd61207-9313-caf7-4f11-e3b128e8bab7-C", "generated_internal_id": "ASST_NON_2018PMBX0017_1550"}, {"internal_id": 69841469, "Award ID": "2018PMBX0016", "Award Amount": 868989.35, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "SOUTH DAKOTA PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5977c26b-55c9-a9b6-4eae-6ac7c2655500-C", "generated_internal_id": "ASST_NON_2018PMBX0016_1550"}, {"internal_id": 69841472, "Award ID": "2018PMBX0015", "Award Amount": 749906.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "2018 BJA COAP CATEGORY 5 HAROLD ROGERS PDMP ENHANCEMENT GRANT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0dd8db32-c4c1-d3b3-4fe7-79361227c1b1-C", "generated_internal_id": "ASST_NON_2018PMBX0015_1550"}, {"internal_id": 69841458, "Award ID": "2018PMBX0014", "Award Amount": 722531.97, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "PENNSYLVANIA PDMP SYSTEM ENHANCEMENT INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f883d24-5b22-bdcc-2a80-1fe9d0f8356b-C", "generated_internal_id": "ASST_NON_2018PMBX0014_1550"}, {"internal_id": 69841476, "Award ID": "2018PMBX0013", "Award Amount": 749851.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "FURTHER ENHANCEMENT OF THE MN PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3e8aa2fc-52a7-d9fc-8c89-c15ca0f3fb64-C", "generated_internal_id": "ASST_NON_2018PMBX0013_1550"}, {"internal_id": 69841459, "Award ID": "2018PMBX0012", "Award Amount": 815905.56, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "CREATING AN INNOVATIVE STRUCTURED DATA REPOSITORY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f67c91cf-d824-5d22-67e1-a6ce7f3be1eb-C", "generated_internal_id": "ASST_NON_2018PMBX0012_1550"}, {"internal_id": 69841511, "Award ID": "2018PMBX0011", "Award Amount": 736313.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "KANSAS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bf25f4c8-865f-2541-885c-7cb500bdfac4-C", "generated_internal_id": "ASST_NON_2018PMBX0011_1550"}, {"internal_id": 69842140, "Award ID": "2018PMBX0010", "Award Amount": 531579.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "FY18 HAROLD ROGERS PDMP SYSTEM ENHANCEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2018PMBX0010_1550"}, {"internal_id": 69841628, "Award ID": "2018PMBX0009", "Award Amount": 466750.58, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "PDMP IMPLEMENTATION AND ENHANCEMENT PROJECTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ca11d49a-d5d1-6d25-24ad-88bc4bad9829-C", "generated_internal_id": "ASST_NON_2018PMBX0009_1550"}, {"internal_id": 69841854, "Award ID": "2018PMBX0008", "Award Amount": 773500.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "OHIO AUTOMATED RX REPORTING SYSTEM (OARRS) ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2018PMBX0008_1550"}, {"internal_id": 69841492, "Award ID": "2018PMBX0007", "Award Amount": 863556.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "TENNESSEE CONTROLLED SUBSTANCES MONITORING DATABASE (CSMD)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "63be0e77-930e-4b89-e9e3-610349642b13-C", "generated_internal_id": "ASST_NON_2018PMBX0007_1550"}, {"internal_id": 69841599, "Award ID": "2018PMBX0006", "Award Amount": 638759.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "GUAM DATA ENHANCEMENT & COLLABORATION WITH THE NORTHERN MARIANA ISLANDS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GU", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "24e6ad11-f067-66f7-95be-c2e992c17f54-C", "generated_internal_id": "ASST_NON_2018PMBX0006_1550"}, {"internal_id": 69841460, "Award ID": "2018PMBX0004", "Award Amount": 737604.43, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "IMPROVING UTAH''S PDMP DATA QUALITY AND ACCURACY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ad190718-78aa-6598-2e74-432b73a2d3f5-C", "generated_internal_id": "ASST_NON_2018PMBX0004_1550"}, {"internal_id": 69841484, "Award ID": "2018PMBX0003", "Award Amount": 749270.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "PDMP IMPLEMENTATION AND ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "31a5b8d3-9079-b062-f46b-9178c5e6c477-C", "generated_internal_id": "ASST_NON_2018PMBX0003_1550"}, {"internal_id": 69841461, "Award ID": "2018PMBX0002", "Award Amount": 787896.39, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "COAP CT PRESCRIPTION MONITORING PROGRAM ENHANCEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9f5ab5d3-ee3f-0b37-4bb5-b69a20c9c0a4-C", "generated_internal_id": "ASST_NON_2018PMBX0002_1550"}, {"internal_id": 69841462, "Award ID": "2018PMBX0001", "Award Amount": 622366.75, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "PRESCRIPTION MONITORING PROGRAM ENHANCEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2fe77f63-7397-7d1d-4fa9-0d31ac8caf76-C", "generated_internal_id": "ASST_NON_2018PMBX0001_1550"}, {"internal_id": 69842491, "Award ID": "2018MUMUK025", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "EFFORTS TO ADDRESS SUBSTANCE USE IN CHILD WELFARE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4d57e46-9637-11ab-7bec-0b42644bb57c-C", "generated_internal_id": "ASST_NON_2018MUMUK025_1550"}, {"internal_id": 69841383, "Award ID": "2018ARBXK224", "Award Amount": 0.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "2018 COMPREHENSIVE OPIOID ABUSE SITE-BASED PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2b637ff8-c792-ee05-d2c6-9e4268730c16-C", "generated_internal_id": "ASST_NON_2018ARBXK224_1550"}, {"internal_id": 69842111, "Award ID": "2018ARBXK132", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "MISSISSIPPI COMPREHENSIVE OPIOID ABUSE PROGRAM (MSCOAP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d049c677-25f4-c424-4f54-2faaa15e9b62-C", "generated_internal_id": "ASST_NON_2018ARBXK132_1550"}, {"internal_id": 69841767, "Award ID": "2018ARBXK124", "Award Amount": 266331.82, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "IOWA OPIOID DATA EXCHANGE (IODE)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "20a846f1-2b22-928c-47ae-a90c13722efb-C", "generated_internal_id": "ASST_NON_2018ARBXK124_1550"}, {"internal_id": 69841541, "Award ID": "2018ARBXK121", "Award Amount": 999985.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-22", "CFDA Number": "16.754", "Description": "DUTCHESS COUNTY DATA DRIVEN OPIOID RESPONSE COLLABORATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bd5237d7-6d3b-9a5d-5f20-2c266e123caa-C", "generated_internal_id": "ASST_NON_2018ARBXK121_1550"}, {"internal_id": 69841370, "Award ID": "2018ARBXK120", "Award Amount": 897335.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "COBB OPIOID FATALITY REVIEW PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "26c19110-1d7c-6ad9-1524-1910f587f551-C", "generated_internal_id": "ASST_NON_2018ARBXK120_1550"}, {"internal_id": 69841570, "Award ID": "2018ARBXK106", "Award Amount": 994766.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-28", "CFDA Number": "16.754", "Description": "THE CARDIFF MODEL: PARTNERSHIPS TO ADDRESS OPIOID ABUSE AND VIOLENCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bdf54116-273b-4553-8e8e-33f01d197de6-C", "generated_internal_id": "ASST_NON_2018ARBXK106_1550"}, {"internal_id": 69842216, "Award ID": "2018ARBXK105", "Award Amount": 381018.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-29", "CFDA Number": "16.754", "Description": "OPIOID-RELATED DEATH ANALYSIS INFORMATION-SHARING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "44932f25-6291-d266-8c32-fbd39b29e1de-C", "generated_internal_id": "ASST_NON_2018ARBXK105_1550"}, {"internal_id": 69842112, "Award ID": "2018ARBXK104", "Award Amount": 0.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "THE HOPE INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a66c7b5b-7d90-d535-d4ca-3f96315349fe-C", "generated_internal_id": "ASST_NON_2018ARBXK104_1550"}, {"internal_id": 69841322, "Award ID": "2018ARBXK103", "Award Amount": 943088.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "MUSCOGEE (CREEK) NATIONS COMPREHENSIVE OPIOID ABUSE SITE PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c6ce26ca-473d-bdb3-c1fc-fb29d09fbebe-C", "generated_internal_id": "ASST_NON_2018ARBXK103_1550"}, {"internal_id": 69841305, "Award ID": "2018ARBXK102", "Award Amount": 982835.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "ST. LOUIS OPIOID AND HOMICIDE PREVENTION COMMAND CENTER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "19c0e5f7-7b3b-2dbf-9852-787f029153ed-C", "generated_internal_id": "ASST_NON_2018ARBXK102_1550"}, {"internal_id": 69841562, "Award ID": "2018ARBXK100", "Award Amount": 997889.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "FAIRFAX COUNTY SECURE INTEGRATED DATA APPROACH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dec44633-81fd-a5e0-49b9-3f7a5c3ef655-C", "generated_internal_id": "ASST_NON_2018ARBXK100_1550"}, {"internal_id": 69842328, "Award ID": "2018ARBXK099", "Award Amount": 1500000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "NEW ENGLAND REGIONAL JUDICIAL OPIOID INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "19310b5c-f42d-7cfd-b72f-727dca29d4ef-C", "generated_internal_id": "ASST_NON_2018ARBXK099_1550"}, {"internal_id": 69841560, "Award ID": "2018ARBXK097", "Award Amount": 997971.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "UNIFIED NEXUS FOR LEVERAGING OPIOID CRIME KNOWLEDGE (UNLOCK)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "147e841a-32d5-d2fa-ae13-c808e4a7e703-C", "generated_internal_id": "ASST_NON_2018ARBXK097_1550"}, {"internal_id": 69841539, "Award ID": "2018ARBXK096", "Award Amount": 999990.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "INFORMATION SHARING TO ADDRESS OPIOID ABUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "56429707-ed2c-10d0-3598-4b75080c3431-C", "generated_internal_id": "ASST_NON_2018ARBXK096_1550"}, {"internal_id": 69842113, "Award ID": "2018ARBXK095", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-29", "CFDA Number": "16.754", "Description": "PUBLIC SAFETY  BEHAVIORAL HEALTH  AND PUBLIC HEALTH INFORMATION-SHARING PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "35059a9f-8ccd-cb56-45b7-ab1e5092969c-C", "generated_internal_id": "ASST_NON_2018ARBXK095_1550"}, {"internal_id": 69841563, "Award ID": "2018ARBXK093", "Award Amount": 997701.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "OPIOID SUPPLY AND DEMAND REDUCTION AND OUTREACH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "72aa1bf7-480c-d819-a744-f7d771947bcc-C", "generated_internal_id": "ASST_NON_2018ARBXK093_1550"}, {"internal_id": 69842114, "Award ID": "2018ARBXK065", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-29", "CFDA Number": "16.754", "Description": "THE EMERGENCY MEDICAL OVERDOSE SURVEILLANCE SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0bbdc747-bd28-0c43-b741-e4cbf4056a75-C", "generated_internal_id": "ASST_NON_2018ARBXK065_1550"}, {"internal_id": 69841566, "Award ID": "2018ARBXK049", "Award Amount": 996408.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "NALOXONE REENTRY TRACKING PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6815fa42-35af-75b2-4623-a91ccee61cd7-C", "generated_internal_id": "ASST_NON_2018ARBXK049_1550"}, {"internal_id": 69841568, "Award ID": "2018ARBXK048", "Award Amount": 0.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-29", "CFDA Number": "16.754", "Description": "EVIDENCE-BASED RESPONSES TO THE OPIOID EPIDEMIC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8b4e85de-1c41-b0c6-bd46-995708d391b2-C", "generated_internal_id": "ASST_NON_2018ARBXK048_1550"}, {"internal_id": 69841573, "Award ID": "2018ARBXK047", "Award Amount": 993154.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "ALASKA PUBLIC SAFETY AND PUBLIC HEALTH DRUG OVERDOSES COMMITTEE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "da787dd9-e8ac-c70e-7520-73e79c96154a-C", "generated_internal_id": "ASST_NON_2018ARBXK047_1550"}, {"internal_id": 69842115, "Award ID": "2018ARBXK042", "Award Amount": 773642.29, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "DRUG OVERDOSE DEATH DATA SUBMISSION SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f883d24-5b22-bdcc-2a80-1fe9d0f8356b-C", "generated_internal_id": "ASST_NON_2018ARBXK042_1550"}, {"internal_id": 69841544, "Award ID": "2018ARBXK041", "Award Amount": 999979.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-29", "CFDA Number": "16.754", "Description": "CATEGORY 6: PUBLIC SAFETY AND PUBLIC HEALTH INFORMATION-SHARING PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d3f84876-c4fb-985c-d2da-6d4468d1c933-C", "generated_internal_id": "ASST_NON_2018ARBXK041_1550"}, {"internal_id": 69841331, "Award ID": "2018ARBXK039", "Award Amount": 920308.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "WV COMPREHENSIVE OPIOID ABUSE SITE-BASED PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "74b936bd-5131-5fd6-3a82-cd69146dba56-C", "generated_internal_id": "ASST_NON_2018ARBXK039_1550"}, {"internal_id": 69841567, "Award ID": "2018ARBXK038", "Award Amount": 996350.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "FY18 COAP - CATEGORY 6 - IDAD ENHANCEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2018ARBXK038_1550"}, {"internal_id": 69841569, "Award ID": "2018ARBXK037", "Award Amount": 996064.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-23", "CFDA Number": "16.754", "Description": "COMMUNITY OVERDOSE ASSESSMENT TEAMS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c888562e-4e36-c672-abfb-594e60ec9f29-C", "generated_internal_id": "ASST_NON_2018ARBXK037_1550"}, {"internal_id": 69841559, "Award ID": "2018ARBXK035", "Award Amount": 999000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "THE ERIE COUNTY NY OPIOID MORTALITY REVIEW BOARD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2ce17b50-69bc-9bf5-1d15-a46823a834f1-C", "generated_internal_id": "ASST_NON_2018ARBXK035_1550"}, {"internal_id": 69841325, "Award ID": "2018ARBXK033", "Award Amount": 932233.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "NORTHERN DISTRICT OF OHIO OPIOID DATA SHARING ACTION PLAN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "11b8a1bb-8dcc-129d-0612-8103c2cf2dda-C", "generated_internal_id": "ASST_NON_2018ARBXK033_1550"}, {"internal_id": 69841378, "Award ID": "2018ARBXK027", "Award Amount": 875160.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-24", "CFDA Number": "16.754", "Description": "MINNESOTA OPIOID ABUSE SITE-BASED PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "767910ba-8510-44fc-6d15-cac799bc5ac1-C", "generated_internal_id": "ASST_NON_2018ARBXK027_1550"}, {"internal_id": 69842116, "Award ID": "2018ARBXK020", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "ENSURING INFORMATION-SHARING PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84bf6b9e-fe47-1e1a-fee6-53b2e36e4b96-C", "generated_internal_id": "ASST_NON_2018ARBXK020_1550"}, {"internal_id": 69841545, "Award ID": "2018ARBXK019", "Award Amount": 999960.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "PINELLAS COUNTY STRATEGIC INFORMATION SHARING PARTNERSHIP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9e870148-6f08-5ef4-650f-2079be3871a0-C", "generated_internal_id": "ASST_NON_2018ARBXK019_1550"}, {"internal_id": 69842117, "Award ID": "2018ARBXK018", "Award Amount": 1000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-27", "CFDA Number": "16.754", "Description": "CATEGORY 6: PUBLIC SAFETY AND PUBLIC HEALTH INFORMATION-SHARING PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "37ca71a1-c0e8-a7cd-e6d4-32acf157349d-C", "generated_internal_id": "ASST_NON_2018ARBXK018_1550"}, {"internal_id": 69841551, "Award ID": "2018ARBXK016", "Award Amount": 999606.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "BUILDING COLLABORATION AND DATA INFRASTRUCTURE TO FIGHT THE OPIOID EPIDEMIC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "63be0e77-930e-4b89-e9e3-610349642b13-C", "generated_internal_id": "ASST_NON_2018ARBXK016_1550"}, {"internal_id": 69841557, "Award ID": "2018ARBXK015", "Award Amount": 999146.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-09-25", "CFDA Number": "16.754", "Description": "HIDTA/ODMAP- DATA INTEGRATION PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4662dc7b-2dec-8a03-7bf0-e5ebbb360123-C", "generated_internal_id": "ASST_NON_2018ARBXK015_1550"}, {"internal_id": 45253192, "Award ID": "2017PMBXK038", "Award Amount": 538759.2, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "BETTER INTELLIGENCE GATHERING FOR PUBLIC SAFETY AND PUBLIC HEALTH (BIGPUSH)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_2017PMBXK038_1550"}, {"internal_id": 45253191, "Award ID": "2017PMBXK037", "Award Amount": 962064.75, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "REGIONAL JOINT OPIOID INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1ad09d56-9d7a-2cad-2b67-d04e846b0111-C", "generated_internal_id": "ASST_NON_2017PMBXK037_1550"}, {"internal_id": 45253190, "Award ID": "2017PMBXK036", "Award Amount": 485854.08, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "MISSISSIPPI DATA-DRIVEN RESPONSES TO PRESCRIPTION DRUG MISUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d049c677-25f4-c424-4f54-2faaa15e9b62-C", "generated_internal_id": "ASST_NON_2017PMBXK036_1550"}, {"internal_id": 45253189, "Award ID": "2017PMBXK030", "Award Amount": 580247.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "NMDOH COMPREHENSIVE OPIOID ABUSE SITE-BASED PROGRAM: DATA-DRIVEN RESPONSES TO PRESCRIPTION DRUG MISUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8ba15d07-8e80-311c-14d2-386306377f2c-C", "generated_internal_id": "ASST_NON_2017PMBXK030_1550"}, {"internal_id": 45253188, "Award ID": "2017PMBXK029", "Award Amount": 591202.7, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "INFORMATION SHARING ELECTRONIC DASHBOARD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2017PMBXK029_1550"}, {"internal_id": 45253187, "Award ID": "2017PMBXK028", "Award Amount": 600000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "NEBRASKA DATA-DRIVEN RESPONSES TO PRESCRIPTION DRUG MISUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "029201fb-3584-d3e8-463e-e1d59e975a9c-C", "generated_internal_id": "ASST_NON_2017PMBXK028_1550"}, {"internal_id": 45253186, "Award ID": "2017PMBXK026", "Award Amount": 574921.87, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "DATA-DRIVEN RESPONSE TO PRESCRIPTION DRUG MISUSE IN KENTUCKY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c477975b-68db-c3dc-4a79-b95cb9f6ab3e-C", "generated_internal_id": "ASST_NON_2017PMBXK026_1550"}, {"internal_id": 45253185, "Award ID": "2017PMBXK024", "Award Amount": 600000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "SAINT LOUIS COUNTY DATA DRIVEN RESPONSE TO PRESCRIPTION DRUG MISUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468c78ed-336a-bf68-387a-a257b3eb22a0-C", "generated_internal_id": "ASST_NON_2017PMBXK024_1550"}, {"internal_id": 45253184, "Award ID": "2017PMBXK017", "Award Amount": 600000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "ARKANSAS OPIOID ABUSE PROGRAM: DATA-DRIVEN RESPONSES TO PRESCRIPTION DRUG MISUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f67c91cf-d824-5d22-67e1-a6ce7f3be1eb-C", "generated_internal_id": "ASST_NON_2017PMBXK017_1550"}, {"internal_id": 45253183, "Award ID": "2017PMBXK016", "Award Amount": 520165.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "SUPPORTING ADOPTION OF GUIDELINES FOR PRESCRIBING OPIOIDS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0dd8db32-c4c1-d3b3-4fe7-79361227c1b1-C", "generated_internal_id": "ASST_NON_2017PMBXK016_1550"}, {"internal_id": 45253182, "Award ID": "2017PMBXK004", "Award Amount": 987620.85, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-01", "CFDA Number": "16.754", "Description": "BRANDEIS PDMP TRAINING AND TECHNICAL ASSISTANCE CENTER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cbfadf27-8176-30f2-9f5f-7e229ff247ef-C", "generated_internal_id": "ASST_NON_2017PMBXK004_1550"}, {"internal_id": 45253181, "Award ID": "2017PMBX0021", "Award Amount": 359414.68, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2017-09-27", "CFDA Number": "16.754", "Description": "IOWA PRESCRIPTION MONITORING PROGRAM ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2555f7fc-4bad-7a0b-ac36-903e91cf7bbd-C", "generated_internal_id": "ASST_NON_2017PMBX0021_1550"}, {"internal_id": 45253180, "Award ID": "2017PMBX0012", "Award Amount": 396734.24, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "FY 2017 NH PDMP CATEGORY 5 APPLICATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "70829962-0377-1b84-37cb-4ced6a0d88e7-C", "generated_internal_id": "ASST_NON_2017PMBX0012_1550"}, {"internal_id": 45253179, "Award ID": "2017PMBX0011", "Award Amount": 399019.34, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "HAROLD ROGERS PRESCRIPTION DRUG MONITORING GRANT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9aef8afa-daa8-fb14-4a71-e9df3274b79d-C", "generated_internal_id": "ASST_NON_2017PMBX0011_1550"}, {"internal_id": 45253178, "Award ID": "2017PMBX0010", "Award Amount": 399184.34, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "ST. LOUIS COUNTY PDMP ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468c78ed-336a-bf68-387a-a257b3eb22a0-C", "generated_internal_id": "ASST_NON_2017PMBX0010_1550"}, {"internal_id": 45253177, "Award ID": "2017PMBX0009", "Award Amount": 310936.34, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "SUPPORT FOR EHR INTEGRATIONS AND PROVIDER FEEDBACK REPORTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0dd8db32-c4c1-d3b3-4fe7-79361227c1b1-C", "generated_internal_id": "ASST_NON_2017PMBX0009_1550"}, {"internal_id": 45253176, "Award ID": "2017PMBX0008", "Award Amount": 161621.4, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "PRESCRIBER'S REPORT CARD ENHANCEMENT TO THE KANSAS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bf25f4c8-865f-2541-885c-7cb500bdfac4-C", "generated_internal_id": "ASST_NON_2017PMBX0008_1550"}, {"internal_id": 45253175, "Award ID": "2017PMBX0006", "Award Amount": 255462.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "STATE OF ALASKA PDMP IMPLEMENTATION AND ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "da787dd9-e8ac-c70e-7520-73e79c96154a-C", "generated_internal_id": "ASST_NON_2017PMBX0006_1550"}, {"internal_id": 45253174, "Award ID": "2017PMBX0005", "Award Amount": 153756.95, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "INDIANA PROFESSIONAL LICENSING AGENCY INSPECT IMPROVEMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bc28df42-3aaa-bfb0-4506-19e2ca6fd36f-C", "generated_internal_id": "ASST_NON_2017PMBX0005_1550"}, {"internal_id": 45253173, "Award ID": "2017PMBX0004", "Award Amount": 400000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "WI EPDMP USER-LED ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_2017PMBX0004_1550"}, {"internal_id": 45253172, "Award ID": "2017PMBX0003", "Award Amount": 399918.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "16.754", "Description": "OHIO AUTOMATED RX REPORTING SYSTEM (OARRS) ENHANCEMENT GRANT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2017PMBX0003_1550"}, {"internal_id": 45253171, "Award ID": "2017PMBX0002", "Award Amount": 379929.09, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2017-09-27", "CFDA Number": "16.754", "Description": "PUERTO RICO PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ccec1439-4fc7-aa7b-66d5-8ed9ab9f57bb-C", "generated_internal_id": "ASST_NON_2017PMBX0002_1550"}, {"internal_id": 45251794, "Award ID": "2017ARBXK003", "Award Amount": 52711336.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-01", "CFDA Number": "16.754", "Description": "COAP NETWORK TRAINING AND TECHNICAL ASSISTANCE COORDINATION PROVIDER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7fa6e978-fa6f-3498-fedb-fd43149fe3ce-C", "generated_internal_id": "ASST_NON_2017ARBXK003_1550"}, {"internal_id": 45251793, "Award ID": "2017ARBXK002", "Award Amount": 695707.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-25", "CFDA Number": "16.838", "Description": "PROMOTING PEER RECOVERY SUPPORT SERVICES IN CRIMINAL JUSTICE AND CHILD WELFARE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "47494177-5b18-4343-11dc-ada590414b67-C", "generated_internal_id": "ASST_NON_2017ARBXK002_1550"}, {"internal_id": 45251792, "Award ID": "2017ARBXK001", "Award Amount": 2600000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-01", "CFDA Number": "16.838", "Description": "COAP CATEGORY B TTA PROVIDER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2dc793ac-1e68-c00a-0170-e62f36b70d7f-C", "generated_internal_id": "ASST_NON_2017ARBXK001_1550"}, {"internal_id": 45249360, "Award ID": "2016PMBXK008", "Award Amount": 587771.22, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-16", "CFDA Number": "16.754", "Description": "EVALUATE AND IMPROVE PRESCRIBING PRACTICES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ad190718-78aa-6598-2e74-432b73a2d3f5-C", "generated_internal_id": "ASST_NON_2016PMBXK008_1550"}, {"internal_id": 45249358, "Award ID": "2016PMBXK006", "Award Amount": 580000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "MICHIGAN DATA-DRIVEN RESPONSES TO PRESCRIPTION DRUG ABUSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0881743a-75ce-105b-b303-c78f16662fd7-C", "generated_internal_id": "ASST_NON_2016PMBXK006_1550"}, {"internal_id": 45249357, "Award ID": "2016PMBXK005", "Award Amount": 565447.32, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ENHANCE PDMP BEST PRACTICES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_2016PMBXK005_1550"}, {"internal_id": 45249356, "Award ID": "2016PMBXK004", "Award Amount": 561060.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "OVERDOSE FATALITY REVIEW ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3c30f51b-0198-c278-4848-50104ea4824f-C", "generated_internal_id": "ASST_NON_2016PMBXK004_1550"}, {"internal_id": 45249355, "Award ID": "2016PMBXK003", "Award Amount": 595774.66, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "REGIONAL APPROACHES TO DECREASE OPIOID OVERDOSE AND DEATHS IN THE PORTLAND METROPOLITAN TRI-COUNTY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3cf78f58-9320-8e79-51d4-2b0ff84703af-C", "generated_internal_id": "ASST_NON_2016PMBXK003_1550"}, {"internal_id": 45249354, "Award ID": "2016PMBXK002", "Award Amount": 562105.83, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "TENNESSEE STRATEGIC WAREHOUSE ANALYTICS TEAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "63be0e77-930e-4b89-e9e3-610349642b13-C", "generated_internal_id": "ASST_NON_2016PMBXK002_1550"}, {"internal_id": 45249353, "Award ID": "2016PMBXK001", "Award Amount": 495374.72, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "LOWELL OPIOID OVERDOSE PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0b5c86e6-59a2-2911-fc26-de13360e98ec-C", "generated_internal_id": "ASST_NON_2016PMBXK001_1550"}, {"internal_id": 45249352, "Award ID": "2016PMBX0012", "Award Amount": 400000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "SOUTH DAKOTA PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5977c26b-55c9-a9b6-4eae-6ac7c2655500-C", "generated_internal_id": "ASST_NON_2016PMBX0012_1550"}, {"internal_id": 45249351, "Award ID": "2016PMBX0011", "Award Amount": 352018.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "MISSISSIPPI BOARD OF PHARMACY PRESCRIPTION MONITORING PROGRAM HR 2016 GRANT APPLICATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f955a2af-1ec4-b996-9f00-6e46cf2dd907-C", "generated_internal_id": "ASST_NON_2016PMBX0011_1550"}, {"internal_id": 45249350, "Award ID": "2016PMBX0010", "Award Amount": 373000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "MICHIGAN PDMP INTERFACE ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0881743a-75ce-105b-b303-c78f16662fd7-C", "generated_internal_id": "ASST_NON_2016PMBX0010_1550"}, {"internal_id": 45249349, "Award ID": "2016PMBX0009", "Award Amount": 400000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "CONNECTICUT PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9f5ab5d3-ee3f-0b37-4bb5-b69a20c9c0a4-C", "generated_internal_id": "ASST_NON_2016PMBX0009_1550"}, {"internal_id": 45249348, "Award ID": "2016PMBX0008", "Award Amount": 399985.91, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ALABAMA'S PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ca11d49a-d5d1-6d25-24ad-88bc4bad9829-C", "generated_internal_id": "ASST_NON_2016PMBX0008_1550"}, {"internal_id": 45249347, "Award ID": "2016PMBX0007", "Award Amount": 340518.28, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "OHIO AUTOMATED RX REPORTING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2016PMBX0007_1550"}, {"internal_id": 45249346, "Award ID": "2016PMBX0006", "Award Amount": 227603.81, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ENHANCING THE MN PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3e8aa2fc-52a7-d9fc-8c89-c15ca0f3fb64-C", "generated_internal_id": "ASST_NON_2016PMBX0006_1550"}, {"internal_id": 45249345, "Award ID": "2016PMBX0005", "Award Amount": 399769.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ARIZONA CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ae9d9e0a-8837-9aed-7186-8ad3880a2c08-C", "generated_internal_id": "ASST_NON_2016PMBX0005_1550"}, {"internal_id": 45249344, "Award ID": "2016PMBX0004", "Award Amount": 390780.0, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ILLINOIS PRESCRIPTION MONITORING PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76cf737b-6066-d86b-2865-0295d98359df-C", "generated_internal_id": "ASST_NON_2016PMBX0004_1550"}, {"internal_id": 45249343, "Award ID": "2016PMBX0003", "Award Amount": 399463.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ENHANCING THE KENTUCKY ALL SCHEDULE PRESCRIPTION ELECTRONIC REPORTING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_2016PMBX0003_1550"}, {"internal_id": 45249342, "Award ID": "2016PMBX0002", "Award Amount": 327494.18, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2016-09-20", "CFDA Number": "16.754", "Description": "ARKANSAS PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f67c91cf-d824-5d22-67e1-a6ce7f3be1eb-C", "generated_internal_id": "ASST_NON_2016PMBX0002_1550"}, {"internal_id": 45249341, "Award ID": "2016PMBX0001", "Award Amount": 376924.85, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2016-09-16", "CFDA Number": "16.754", "Description": "GUAM PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GU", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "24e6ad11-f067-66f7-95be-c2e992c17f54-C", "generated_internal_id": "ASST_NON_2016PMBX0001_1550"}, {"internal_id": 45243327, "Award ID": "2015PMBXK005", "Award Amount": 419567.17, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-15", "CFDA Number": "16.754", "Description": "PDMP PRACTITIONER AND RESEARCH PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "72aa1bf7-480c-d819-a744-f7d771947bcc-C", "generated_internal_id": "ASST_NON_2015PMBXK005_1550"}, {"internal_id": 45243326, "Award ID": "2015PMBXK004", "Award Amount": 750000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "PDMP PRACTITIONER AND RESEARCH PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f0e17ae4-fc2b-6e41-557e-d243f5bbb5d6-C", "generated_internal_id": "ASST_NON_2015PMBXK004_1550"}, {"internal_id": 45243325, "Award ID": "2015PMBXK003", "Award Amount": 660231.97, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-02-24", "CFDA Number": "16.754", "Description": "PDMP PRACTITIONER AND RESEARCH PARTNERSHIP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "04c91383-4791-7851-87fe-3cebca9b8ce1-C", "generated_internal_id": "ASST_NON_2015PMBXK003_1550"}, {"internal_id": 45243324, "Award ID": "2015PMBXK002", "Award Amount": 703932.37, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "HIGH RISK PRESCRIPTION DRUG USERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3c30f51b-0198-c278-4848-50104ea4824f-C", "generated_internal_id": "ASST_NON_2015PMBXK002_1550"}, {"internal_id": 45243323, "Award ID": "2015PMBXK001", "Award Amount": 698666.03, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "CALIFORNIA PDMP ENHANCEMENT, ANALYSIS AND RESPONSE INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "87af3ad1-955d-6282-9592-3ae0bf29dc15-C", "generated_internal_id": "ASST_NON_2015PMBXK001_1550"}, {"internal_id": 45243320, "Award ID": "2015PMBX0010", "Award Amount": 331292.89, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "MONTANA PRESCRIPTION DRUG REGISTRY PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fcf00ed5-ba93-a09a-2662-7aaa9b3d31b7-R", "generated_internal_id": "ASST_NON_2015PMBX0010_1550"}, {"internal_id": 45243318, "Award ID": "2015PMBX0008", "Award Amount": 421675.78, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "PRESCRIPTION DRUG MONITORING ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0f7f672e-1cc8-1e61-1451-a9cb548d3a6e-C", "generated_internal_id": "ASST_NON_2015PMBX0008_1550"}, {"internal_id": 45243317, "Award ID": "2015PMBX0007", "Award Amount": 145495.73, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "AUTOMATED RX REPORTING SYSTEM ENHANCEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_2015PMBX0007_1550"}, {"internal_id": 45243316, "Award ID": "2015PMBX0006", "Award Amount": 493551.29, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "IMPLEMENTATION AND ENHANCEMENT OF PRESCRIPTION DRUG MONITORING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "70829962-0377-1b84-37cb-4ced6a0d88e7-C", "generated_internal_id": "ASST_NON_2015PMBX0006_1550"}, {"internal_id": 45243315, "Award ID": "2015PMBX0005", "Award Amount": 453548.03, "Award Type": null, "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "PDMP IMPLEMENTATION AND ENHANCEMENT PROJECT 2015", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "029201fb-3584-d3e8-463e-e1d59e975a9c-C", "generated_internal_id": "ASST_NON_2015PMBX0005_1550"}, {"internal_id": 45243314, "Award ID": "2015PMBX0004", "Award Amount": 232695.31, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_2015PMBX0004_1550"}, {"internal_id": 45243313, "Award ID": "2015PMBX0003", "Award Amount": 337125.54, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "ACHIEVING BETTER CARE BY MONITORING ALL PRESCRIPTIONS (ABC-MAP) PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f883d24-5b22-bdcc-2a80-1fe9d0f8356b-C", "generated_internal_id": "ASST_NON_2015PMBX0003_1550"}, {"internal_id": 45243312, "Award ID": "2015PMBX0002", "Award Amount": 299588.06, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2015-09-18", "CFDA Number": "16.754", "Description": "2015 PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f181d4c2-1fa0-1f32-a106-d3700bad68a3-C", "generated_internal_id": "ASST_NON_2015PMBX0002_1550"}, {"internal_id": 45237271, "Award ID": "2014PMBXK001", "Award Amount": 3106028.79, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2014-09-04", "CFDA Number": "16.751", "Description": "BJA FY 14 HAROLD ROGERS PRESCRIPTION DRUG MONITORING NATIONAL TRAINING AND TECHNICAL ASSISTANCE PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cbfadf27-8176-30f2-9f5f-7e229ff247ef-C", "generated_internal_id": "ASST_NON_2014PMBXK001_1550"}, {"internal_id": 45237269, "Award ID": "2014PMBX0014", "Award Amount": 389919.62, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-03", "CFDA Number": "16.754", "Description": "MASSACHUSETTS PDMP PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9aef8afa-daa8-fb14-4a71-e9df3274b79d-C", "generated_internal_id": "ASST_NON_2014PMBX0014_1550"}, {"internal_id": 45237267, "Award ID": "2014PMBX0012", "Award Amount": 338972.44, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-03", "CFDA Number": "16.754", "Description": "WISCONSIN PDMP PUBLIC HEALTH PORTAL ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_2014PMBX0012_1550"}, {"internal_id": 45237265, "Award ID": "2014PMBX0010", "Award Amount": 399346.88, "Award Type": null, "Base Obligation Date": "2014-09-09", "CFDA Number": "16.754", "Description": "DATA-DRIVEN MULTIDISCIPLINARY APPROACHES TO REDUCING THE PRESCRIPTION DRUG ABUSE IN KENTUCKY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c477975b-68db-c3dc-4a79-b95cb9f6ab3e-C", "generated_internal_id": "ASST_NON_2014PMBX0010_1550"}, {"internal_id": 45237263, "Award ID": "2014PMBX0008", "Award Amount": 287362.0, "Award Type": null, "Base Obligation Date": "2014-09-09", "CFDA Number": "16.754", "Description": "ENHANCING THE VERMONT PRESCRIPTION MONITORING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "56429707-ed2c-10d0-3598-4b75080c3431-C", "generated_internal_id": "ASST_NON_2014PMBX0008_1550"}, {"internal_id": 45237260, "Award ID": "2014PMBX0005", "Award Amount": 396758.89, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-01-31", "CFDA Number": "16.754", "Description": "NEW MEXICO PRESCRIPTION MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bcd61207-9313-caf7-4f11-e3b128e8bab7-C", "generated_internal_id": "ASST_NON_2014PMBX0005_1550"}, {"internal_id": 45237258, "Award ID": "2014PMBX0003", "Award Amount": 363738.84, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-09", "CFDA Number": "16.754", "Description": "THE ARIZONA PRESCRIPTION DRUG MISUSE AND ABUSE INITIATIVE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "af6a05f9-eca8-3557-ae27-f885e4abc8af-C", "generated_internal_id": "ASST_NON_2014PMBX0003_1550"}, {"internal_id": 45237257, "Award ID": "2014PMBX0002", "Award Amount": 360496.63, "Award Type": null, "Base Obligation Date": "2014-09-03", "CFDA Number": "16.754", "Description": "PRESCRIPTION DRUG & SUBSTANCE ABUSE CHANGE APPROACH FOR DELAWARE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e5a11e99-a18b-0acf-ae2f-e903c0081f06-C", "generated_internal_id": "ASST_NON_2014PMBX0002_1550"}, {"internal_id": 45231471, "Award ID": "2013PMBX0010", "Award Amount": 394932.79, "Award Type": null, "Base Obligation Date": "2013-09-03", "CFDA Number": "16.754", "Description": "SEIZING THE MOMENTUM: A MULTIDISCIPLINARY APPROACH TO REDUCE RX DRUG ABUSE IN FLORIDA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "31a5b8d3-9079-b062-f46b-9178c5e6c477-C", "generated_internal_id": "ASST_NON_2013PMBX0010_1550"}, {"internal_id": 45231467, "Award ID": "2013PMBX0006", "Award Amount": 176135.64, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-09-03", "CFDA Number": "16.754", "Description": "PRESCRIPTION DRUG MONITORING IMPLEMENTATION AND ENHANCEMENT PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "78e2168c-91dc-4ee3-f4cb-fb8e0cff6ea8-C", "generated_internal_id": "ASST_NON_2013PMBX0006_1550"}, {"internal_id": 45231465, "Award ID": "2013PMBX0004", "Award Amount": -149256.1, "Award Type": "BLOCK GRANT (A)", "Base Obligation Date": "2013-09-03", "CFDA Number": "16.754", "Description": "GUAM PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GU", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "24e6ad11-f067-66f7-95be-c2e992c17f54-C", "generated_internal_id": "ASST_NON_2013PMBX0004_1550"}, {"internal_id": 45225650, "Award ID": "2012PMBX0004", "Award Amount": 323624.46, "Award Type": null, "Base Obligation Date": "2012-08-29", "CFDA Number": "16.754", "Description": "ENHANCEMENT OF NORTH CAROLINA''S CONTROLLED SUBSTANCES REPORTING SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "44c05f0e-2559-a608-5a78-7cedb80b5c53-C", "generated_internal_id": "ASST_NON_2012PMBX0004_1550"}, {"internal_id": 45219427, "Award ID": "2011PMBXK001", "Award Amount": 1886950.45, "Award Type": null, "Base Obligation Date": "2011-09-08", "CFDA Number": "16.571", "Description": "PRESCRIPTION DRUG MONITORING PROGRAM NATIONAL TRAINING AND TECHNICAL ASSISTANCE CENTER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cbfadf27-8176-30f2-9f5f-7e229ff247ef-C", "generated_internal_id": "ASST_NON_2011PMBXK001_1550"}, {"internal_id": 154167978, "Award ID": "15PBJA22GK03122PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "THE GOAL OF\u00a0 THIS GRANT IS TO ENHANCE OUR PDMP\u2019S ABILITY TO PROVIDE TRAINING PROGRAMS AND SUPPORT FOR SYSTEM USERS BY CREATING DOCUMENTATION AND EXPANDING COMMUNICATIONS THAT ENHANCE END USER SYSTEM UTILIZATION, TECHNICAL SYSTEM OPERATION AND MAINTENANCE.\u00a0 THE DISSEMINATION OF THESE EDUCATIONAL MATERIALS WILL IMPROVE THE EFFECTIVENESS OF OUR PDMP AS A TOOL FOR OUR SYSTEM USERS AND THE EFFICIENCY OF OUR TEAM IN SUPPORT OF SYSTEM USERS.\n\n\u00a0\n\nTHIS GRANT WILL\u00a0ENABLE CHFS\u00a0TO ADD A DEDICATED BUSINESS ANALYST TO SERVE IN THE ROLE OF A TECHNICAL WRITER AND COMMUNICATION SPECIALIST.\u00a0 THE KASPER SYSTEM IS UNDERGOING AN EXTENSIVE SYSTEM MODERNIZATION PROJECT WHICH WILL CONCLUDE IN EARLY 2023.\u00a0 THE BUSINESS ANALYST WILL SUPPORT THE DEVELOPMENT AND IMPLEMENTATION OF TRAINING ON THE MODERNIZED KASPER SYSTEM BY THE KASPER PROGRAM ADMINISTRATOR, HELPDESK PERSONNEL, PHARMACIST CONSULTANTS AND OTHERS THROUGH THE FOLLOWING OBJECTIVES:\n\n\n\tTHE BUSINESS ANALYST WILL WORK IN CONCERT WITH THE KASPER PROGRAM ADMINISTRATOR AND TECHNICAL RESOURCES TO CREATE KASPER USER GUIDES AND TRAINING MATERIALS FOR EACH USER ROLE INCLUDING, BUT NOT LIMITED TO, PRESCRIBERS, PHARMACISTS, DELEGATES, LAW ENFORCEMENT, LICENSURE BOARDS AND KASPER STAFF.\u00a0 THESE MATERIALS WILL BE DISSEMINATED IN TRAININGS SESSIONS VIA PROFESSIONAL ASSOCIATION MEETINGS, WEBINARS AND SITE BASED TRAININGS IN ORDER TO ENABLE EFFECTIVE USE OF THE MODERNIZED SYSTEM.\n\tTHE BUSINESS ANALYST WILL WORK IN CONCERT WITH THE KASPER PROGRAM ADMINISTRATOR, KASPER INFORMATION TECHNOLOGY PROJECT MANAGER, AND THE TECHNICAL TEAM TO DEVELOP A KASPER TECHNICAL SUPPORT MANUAL FOR THE MODERNIZED SYSTEM.\u00a0 THIS MANUAL WILL DOCUMENT THE TECHNICAL OPERATION, MAINTENANCE AND SUPPORT OF THE SYSTEM IN DETAIL.\u00a0 THIS WOULD BETTER ENABLE KASPER STAFF TO EFFICIENTLY SUPPORT THE SYSTEM, TROUBLESHOOT ISSUES AND TRAIN NEW TECHNICAL RESOURCES.\u00a0 THIS MANUAL MAY ALSO BE MADE AVAILABLE TO STATES OR TERRITORIES WHO ARE INTERESTED IN IMPLEMENTING AN IN HOUSE SUPPORTED PDMP SYSTEM.\n\tTHE BUSINESS ANALYST WILL WORK IN CONCERT WITH THE KASPER PROGRAM ADMINISTRATOR TO CREATE AND FACILITATE REGULAR COMMUNICATIONS WITH CLINICAL AND NON-CLINICAL USERS VIA KASPER DIRECT MESSAGING (DEVELOPED THROUGH A 2018 BJA HAROLD ROGERS GRANT) AND OTHER COMMUNICATION METHODS.\u00a0 THE COMMUNICATIONS WOULD INCLUDE:\n\t\n\t\tREGULAR EDUCATIONAL COMMUNICATIONS TARGETED AT INCREASING USER KNOWLEDGE OF TECHNICAL FUNCTIONALITY\n\t\tSPECIFIC ISSUES BASED COMMUNICATIONS\n\t\tCOMMUNICATIONS RELATED TO STATUTORY OR REGULATORY CHANGES AND COMPLIANCE WITH STATUTE\n\t\tCOMMUNICATIONS TO SUPPORT THE WORK OF KASPER STAKEHOLDERS SUCH AS FEDERAL AND STATE LAW ENFORCEMENT OR LICENSURE BOARDS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_15PBJA22GK03122PDMP_1550"}, {"internal_id": 156905650, "Award ID": "15PBJA22GK03121PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "PRESCRIPTION DRUG ABUSE CONTINUES TO BE A NATIONAL PUBLIC HEALTH CRISIS.\u00a0 THE NEW JERSEY PRESCRIPTION MONITORING PROGRAM (\"NJPMP\") IS AN IMPORTANT WEAPON IN NEW JERSEY'S ARSENAL TO COMBAT THE ABUSE, MISUSE AND DIVERSION OF PRESCRIPTION DRUGS. SINCE BECOMING OPERATIONAL IN 2011, A TOTAL OF 52,483 PRESCRIBERS AND 7,940 PHARMACISTS HAVE REGISTERED FOR ACCESS TO THE NJPMP, REPRESENTING APPROXIMATELY 99 PERCENT OF ELIGIBLE PRESCRIBERS.\u00a0 TO DATE, OVER 125 MILLION CONTROLLED DANGEROUS SUBSTANCE, HUMAN GROWTH HORMONE AND GABAPENTIN PRESCRIPTIONS HAVE BEEN ENTERED INTO THE NJPMP FROM MORE THAN 3,300 NEW JERSEY LICENSED PHARMACIES. BETWEEN 2018 AND 2020, THE NJPMP INTEGRATED WITH THE ELECTRONIC HEALTH RECORDS (\u201cEHR\u201d) SYSTEMS OF OVER 375 HOSPITAL SYSTEMS, PHARMACIES, AND OTHER HEALTHCARE ENTITIES, REPRESENTING THOUSANDS OF LOCATIONS ACROSS THE TRISTATE AREA, INCLUDING SOME OF NEW JERSEY\u2019S LARGEST HOSPITAL SYSTEMS AND CHAIN PHARMACIES. EHR INTEGRATION FACILITATED OVER 1.2 MILLION PATIENT QUERIES IN 2018. SINCE THEN, THAT NUMBER HAS EXPANDED EXPONENTIALLY: THERE WERE OVER 19.5 MILLION PATIENT QUERIES IN 2019, AND OVER 48.7 MILLION PATIENT QUERIES IN 2020. \n\nTHE DEPARTMENT OF LAW AND PUBLIC SAFETY AND THE NEW JERSEY DIVISION OF CONSUMER AFFAIRS ARE SEEKING FUNDING IN THE AMOUNT OF $1,400,000 TO MAKE THE FOLLOWING FIVE (5) ENHANCEMENTS DESIGNED TO IMPROVE NJPMP INFORMATION, REPORTING, QUALITY, AND INTEGRITY WHICH WILL ALLOW FOR BETTER CLINICAL DECISION MAKING BY PRESCRIBERS AS WELL AS FURTHER NEW JERSEY\u2019S EFFORTS TO PREVENT THE ABUSE, MISUSE AND DIVERSION OF CONTROLLED SUBSTANCES. \n\n\n\tDEVELOP AN INVESTIGATION ALERT MODULE; \n\tDEVELOP A NJPMP REPORTING EXEMPTION MODULE;\u00a0 \n\tCREATE A PUBLIC NJPMP DATA DASHBOARD; \n\tDEVELOP AN INTERACTIVE REPORTING MODULE FOR THE DIVISION\u2019S ENFORCEMENT BUREAU; AND\n\tIMPLEMENT NJPMP PROGRAMMATIC ENHANCEMENTS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_15PBJA22GK03121PDMP_1550"}, {"internal_id": 154165603, "Award ID": "15PBJA22GK03120PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-28", "CFDA Number": "16.754", "Description": "PROJECT ABSTRACT \n\nBUREAU OF JUSTICE ASSISTANCE \n\nFISCAL YEAR (FY) 22 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP) AMOUNT REQUESTED $1,396,640\n\nTHE PURPOSE OF THIS PROPOSAL IS TO REQUEST FUNDING IN THE AMOUNT OF $1,396,640 FROM THE FY 22\u00a0PDMP TO COMPLETE ENHANCEMENTS TO CALIFORNIA\u2019S CONTROLLED SUBSTANCE UTILIZATION REVIEW AND EVALUATION SYSTEM (CURES) THROUGH TECHNOLOGICAL UPGRADES THAT WILL IMPROVE THE CURES\u2019 DATA COLLECTION PROCESS, FEATURES, AND SERVICES. \u00a0IN AN EFFORT TO IMPROVE CURES FEATURES AND REDUCE THE TECHNICAL DEBT THAT CURRENTLY EXISTS, AN EVALUATION AND FEASIBILITY STUDY WILL BE CONDUCTED TO VALIDATE CURRENT USAGE AND IMPLEMENTATION OF THE REPORTING TOOLS IN USE VERSUS TOOLS AVAILABLE WITH THE CURRENT TECHNOLOGY IN AN EFFORT TO PROVIDE BETTER REPORTS TO DETECT AND PREVENT THE DIVERSION AND ABUSE OF CONTROLLED SUBSTANCES SUCH AS OPIOIDS, BENZODIAZEPINES, AND CARISOPRODOLS.\u00a0 ADDITIONALLY, FUNDING WILL BE USED TO MAINTAIN THE DATA COLLECTION SERVICES AND FUND THE STATISTICAL ANALYSIS SOFTWARE (SAS) LICENSE AND SUPPORT COSTS.\u00a0 \n\nUPON AWARDING THE FY 22 FUNDS TO THE PDMP, THE FUNDING WILL BE UTILIZED FOR:\n\n\n\tDATA COLLECTION SERVICES \u2013 FUNDING WILL BE USED TO FINANCE DATA COLLECTION SERVICES.\n\n\n\u00a0\n\n\n\tSAS LICENSE AND SUPPORT \u2013 FUNDING WILL BE USED TO FINANCE THE 2023- 2024 LICENSE RENEWAL AND MAINTENANCE OF SAS.\n\n\n\u00a0\n\n\n\tCONSULTANT RESOURCES \u2013 FUNDING WILL FINANCE CONSULTANT RESOURCES FOR SYSTEM MODIFICATIONS TO UPGRADE CURES FEATURES AND STANDARDS.\u00a0 ADDITIONALLY, THE CALIFORNIA DEPARTMENT OF JUSTICE (CA DOJ) WILL HIRE CONSULTING COMPANIES TO DO AN EVALUATION AND FEASIBILITY STUDY ON THE BEST REPORTING AND ANALYTIC TOOL FOR CURES.\n\n\n\u00a0\n\n\n\tPDMP-RELATED MEETINGS ATTENDANCE \u2013 FUNDING WILL BE USED TO FINANCE TRAVEL FOR PDMP-RELATED MEETINGS. \n\n\nTHE CURRENT STATE REIMBURSEMENT AND OTHER GRANT FUNDING THE CA DOJ RECEIVES TO OPERATE THE CURES DOES NOT COVER ALL COSTS FOR THESE EFFORTS.\u00a0 IF THIS GRANT IS NOT AWARDED, CURES MUST CONTINUE TO SUPPORT OBSOLETE STANDARDS; CONSEQUENTIALLY, MAINTAINING THE CURRENT TECHNICAL DEBT IMPOSED BY SUPPORTING OBSOLETE STANDARDS. \u00a0ADDITIONALLY, UPGRADES TO IMPROVE CURES WILL BE DEFERRED.\u00a0 DENIAL OF THIS PROPOSAL ADDS FISCAL BURDEN SINCE THE CURRENT STATE REIMBURSEMENT AND OTHER GRANT FUNDING THAT THE CA DOJ RECEIVES TO MAINTAIN AND OPERATE CURES DOES NOT COVER ALL THESE COSTS.\n\nTHIS PROPOSAL WOULD ALSO ALLOW THE CA DOJ TO FURTHER THE GOALS AND OBJECTIVES OF THE FY 22 PDMP FUNDING.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "87af3ad1-955d-6282-9592-3ae0bf29dc15-C", "generated_internal_id": "ASST_NON_15PBJA22GK03120PDMP_1550"}, {"internal_id": 154168716, "Award ID": "15PBJA22GK03119PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "THE PR-PDMP WAS IMPLEMENTED IN 2018 UNDER PR LAW 70 OF 2017. EFFORTS WERE DIRECTED TO ATTEND THE PR OPIOID ALERT, ADDING PRESCRIBER REPORT CARDS, ADVANCED ANALYTICS, CLINICAL ALERTS AND RXCHECK. THE PROPOSED GRANT WILL BE USED TO MAINTAIN THE RED FLAGS PROJECT, AND CREATE EDUCATIONAL CAMPAIGNS TARGETED TO PATIENTS, PRESCRIBERS AND PHARMACISTS ON BENEFITS OF EHR INTEGRATION, REDUCING OVERDOSE EVENTS IN PATIENTS AND INCREASING PRESCRIBERS\u2019 COMPLIANCE. IN THE FIRST TWO YEARS, EFFORTS WERE DIRECTED TO POLICY CHANGES ENABLING THE ESTABLISHMENT AND DISSEMINATION OF THE PDMP PRIMARILY AMONG PHARMACIES TO ENSURE REGISTRATION IN THE SYSTEM, ACHIEVING THAT 98% OF THE PR PHARMACIES OF PR ARE INTEGRATED AND REPORTING REGULARLY. THE PMP AWARE, A COMPUTERIZED ACCOUNT REGISTRATION SYSTEM, AS OF MAY 2022, REFLECTED 5,293 REGISTERED USERS, OF WHICH 2,943 WERE PHARMACISTS OR PHARMACY PERSONNEL, 2,255 PRESCRIBERS, 70 REPRESENTATIVES OF LAW-AND-ORDER AGENCIES, AND 25 OTHER USERS THAT INCLUDE ADMINISTRATIVE PERSONNEL, SOCIAL WORKERS, AND SA COUNSELLORS. SINCE ITS IMPLEMENTATION, IN COLLABORATION WITH PROFESSIONAL ASSOCIATIONS OF PR, TRAINING ON THE USE AND MANAGEMENT OF THE PDMP HAS BEEN GIVEN THROUGHOUT THE ISLAND, IMPACTING MORE THAN 6,000 PROFESSIONALS. NEED FOR CONTINUED PDMP USE AND DEVELOPMENT IS REFLECTED BY DATA SHOWING 17,088,265 CONTROLLED MEDICATIONS PRESCRIPTIONS DISPENSED FROM MAY, 2018 TO MAY, 2022. THE PROPOSED FY 2022 PDMP APPLICATION PROPOSES THE SUMMARIZED GOALS OF 1) INCREASING PR-PDMP CAPACITY TO DETECT/PREVENT DIVERSION AND MISUSE OF OPIOIDS AND OTHER PRESCRIPTION DRUGS BY CONTINUING THE IMPLEMENTATION OF THE RED FLAG PROJECT, AND 2) ENHANCING AWARENESS IN PATIENTS AND BH PROFESSIONALS ABOUT BENEFITS OF THE PDMP AND THE RISKS OF AN OVERDOSE WHEN COMBINING PRESCRIPTIONS THROUGH PUBLIC CAMPAIGNS. OBJECTIVES INCLUDE REDUCING BY 20% OVERDOSE EVENTS REFLECTED IN RED FLAG DATA; INCREASING KNOWLEDGE OF OVERDOSE RISKS IN 250 PATIENTS OVERUSING PRESCRIPTIONS; INSTRUCTING 1,500 PHYSICIANS ON PDMP USE FOR DECISION MAKING; REGISTERING 750 NEW PHYSICIAN USERS; DEVELOPING AN EDUCATIONAL CAMPAIGN TO PATIENTS, AND ANOTHER TO 150 PHYSICIANS AND PHARMACEUTICS PER YEAR ON BENEFITS OF THE PDMP AND EHR INTEGRATION. MHAASA WILL COLLABORATE WITH ENFORCEMENT AND SERVICE PROVIDERS AND APPLY THE EBP\u2019S FOR EPIDEMIOLOGICAL ANALYSIS, INCREASING PDMP UTILIZATION AND INTERSTATE DATA SHARING OVER A 36-MONTH PERIOD TO ACHIEVE THESE GOALS AND OBJECTIVES.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ccec1439-4fc7-aa7b-66d5-8ed9ab9f57bb-C", "generated_internal_id": "ASST_NON_15PBJA22GK03119PDMP_1550"}, {"internal_id": 154166983, "Award ID": "15PBJA22GK03118PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "TO ACHIEVE OUR GOAL IN ENHANCING THE ESTABLISHED PRESCRIPTION DRUG MONITORING PROGRAM (PDMP), THE RHODE ISLAND DEPARTMENT OF HEALTH (RIDOH) IS APPLYING FOR THE FY 2022 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM GRANT IN THE AMOUNT OF $1,400,000. THIS PROJECT WILL SUPPORT ENHANCEMENTS FOR THE RHODE ISLAND (RI) PDMP THAT WILL IMPROVE FUNCTIONALITY, FACILITATE CONNECTIONS WITH HEALTHCARE PROVIDERS, AND SUPPORT CONTINUED SUSTAINABILITY. THE PROPOSED GOALS INCLUDE DEVELOPING PDMP UPGRADES IN PURSUIT OF MEDICAID ENTERPRISE SYSTEMS (MES) CERTIFICATION; ESTABLISHING LINKAGES BETWEEN THE RI PDMP AND OTHER HEALTH INFORMATION SYSTEMS; IMPROVING COMMUNICATIONS WITH PRESCRIBERS, PHARMACIES, STATE AGENCIES, AND STAKEHOLDERS; AND PERFORMING DATA ANALYTICS AND EVALUATIONS THAT WILL HIGHLIGHT POTENTIAL FUTURE PDMP ENHANCEMENTS AS WELL AS LEVERAGE PDMP DATA TO HELP INFORM STATEWIDE RESPONSE TO THE OPIOID EPIDEMIC. THIS FUNDING WILL GREATLY SERVE RESIDENTS AND HEALTH CARE PRACTITIONERS ACROSS THE ENTIRE STATE. RIDOH HAS FORMED NUMEROUS INTERNAL AND EXTERNAL PARTNERSHIPS THAT CONTRIBUTE TO THE GOVERNANCE, DEVELOPMENT, AND MAINTENANCE OF THE PDMP. RIDOH IS WORKING WITH THE RHODE ISLAND EXECUTIVE OFFICE OF HEALTH AND HUMAN SERVICES (EOHHS) TO SECURE CMS FUNDING FOR STAFF AND ENHANCEMENTS THAT WILL BE REQUIRED FOR ONGOING SUSTAINABILITY. THE TEAM ALSO COLLABORATES CLOSELY WITH THE RHODE ISLAND DEPARTMENT OF BEHAVIORAL HEALTH, DEVELOPMENTAL DISABILITIES, AND HOSPITALS (BHDDH), TO SHARE INFORMATION PERTAINING TO OVERDOSE TRENDS, COMMUNITY OUTREACH, AND EFFORTS RELATED TO PREVENTION, RESCUE, TREATMENT, AND RECOVERY. THE PDMP TEAM ALSO CONTRIBUTES TO THE GOVERNOR\u2019S RHODE ISLAND OVERDOSE PREVENTION AND INTERVENTION TASK FORCE, A STATEWIDE COMMITTEE COMPRISED OF MEMBERS FROM RIDOH, BHDDH, THE GOVERNOR\u2019S OFFICE, CLINICIANS, FIRST RESPONDERS, INDIVIDUALS IN RECOVERY, AND COMMUNITY ORGANIZATIONS. OUTCOMES OF THIS PROJECT WILL INCLUDE IMPROVING EASE OF PDMP ACCESS AND USE FOR PRACTITIONERS, FACILITATING PDMP INTEGRATION INTO HEALTH SYSTEMS INCLUDING MEDICAID, AND ENHANCING DATA COLLECTION AND EVALUATION THAT WILL INFORM FUTURE DEVELOPMENT AND SUSTAINABILITY OF THE PDMP.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f0e17ae4-fc2b-6e41-557e-d243f5bbb5d6-C", "generated_internal_id": "ASST_NON_15PBJA22GK03118PDMP_1550"}, {"internal_id": 154165629, "Award ID": "15PBJA22GK03117PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "FY 2022 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM \n\nFEDERAL AMOUNT REQUESTED: $1,350,000\n\nGEOGRAPHIC AREA: OHIO\n\nONE OF THE BEST TOOLS AVAILABLE TO PREVENT THE DIVERSION AND ABUSE OF CONTROLLED SUBSTANCE MEDICATIONS IN OHIO IS THE STATE\u2019S PRESCRIPTION DRUG MONITORING PROGRAM (PDMP), KNOWN AS THE OHIO AUTOMATED RX REPORTING SYSTEM (OARRS). OARRS IS A SYSTEM DEVELOPED TO DETECT THE DIVERSION, ABUSE, AND MISUSE OF CONTROLLED SUBSTANCES. OARRS IS OPERATED BY THE STATE OF OHIO BOARD OF PHARMACY (BOARD). \n\nTHE PROPOSED PROJECT SEEKS TO PROMOTE COLLABORATION AMONG THE BOARD, LAW ENFORCEMENT, AND PROSECUTORS BY FUNDING FOUR BOARD OF PHARMACY ENFORCEMENT AGENTS (OARRS AGENTS) TO CONDUCT CRIMINAL INVESTIGATIONS OF DRUG DIVERSION UTILIZING DATA FROM OHIO\u2019S PDMP, OARRS.\u00a0 THE OARRS AGENTS WILL WORK CLOSELY WITH FEDERAL, STATE, AND LOCAL LAW ENFORCEMENT WITH THE GOAL OF DISRUPTING THE SUPPLY OF DRUGS DIVERTED FROM THE HEALTHCARE SYSTEM.\u00a0 OARRS AGENTS WILL BE RESPONSIBLE FOR ACTIVITIES SUCH AS: ANALYZING OARRS DATA TO IDENTIFY POTENTIAL VIOLATIONS OF OHIO LAW, CONDUCTING INVESTIGATIONS OF HEALTHCARE PROVIDERS, AND PROVIDING TRAINING TO STATE AND LOCAL LAW ENFORCEMENT ON THE USE OF OARRS FOR CRIMINAL INVESTIGATIONS. \n\nTHE FOLLOWING PARTNERS HAVE AGREED TO SUPPORT THIS PROJECT: RECOVERYOHIO, OHIO ATTORNEY GENERAL, STATE MEDICAL BOARD OF OHIO, OHIO DEPARTMENT OF PUBLIC SAFETY, OHIO BOARD OF NURSING, NATIONAL ASSOCIATION OF DRUG DIVERSION INVESTIGATORS, AND THE TRUMBULL ACTION GROUP DRUG TASK FORCE.\u00a0\n\nTHE BOARD OF PHARMACY GRANTS THE OFFICE OF JUSTICE PROGRAMS PERMISSION TO SHARE THIS PROJECT ABSTRACT WITH THE PUBLIC.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_15PBJA22GK03117PDMP_1550"}, {"internal_id": 154165602, "Award ID": "15PBJA22GK03116PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "TITLE: WISCONSIN EPDMP SELF-SERVICE ENHANCEMENTS\n\nABSTRACT:\n\nTHE WISCONSIN DEPARTMENT OF SAFETY AND PROFESSIONAL SERVICES (DSPS) SEEKS FUNDS TO MODERNIZE AND CREATE NEW SELF-SERVICE FUNCTIONALITY FOR THE WI EPDMP SYSTEM. WITH THE RECENT ACCELERATION OF ONLINE SELF-SERVICE EXPECTATIONS AMONG USERS DRIVING BEHAVIOR TOWARDS AND PERCEPTIONS OF ORGANIZATIONS, OFFERING APPROPRIATE SELF-SERVICE OPTIONS AS PART OF THE EPDMP WILL INCREASE THE EFFICACY OF THE SYSTEM THROUGHOUT THE STATE OF WI. THE SELF-SERVICE ENHANCEMENTS WILL EMPOWER ALL USERS OF THE WI EPDMP TO INTERACT WITH THE SYSTEM MORE EFFICIENTLY AND EFFECTIVELY, LEADING TO IMPROVED DATA QUALITY, INCREASED SECURITY, BETTER CUSTOMER SUPPORT, AND GREATER USER SATISFACTION.\n\nTHE NEW SELF-SERVICE FEATURES INCLUDE THE FOLLOWING THREE DELIVERABLES:\n\n\n\tIMPROVED ON-DEMAND AND INTERACTIVE TRAINING AND TESTING MATERIALS FOR DATA SUBMITTERS, LAW ENFORCEMENT AGENCIES AND HEALTHCARE PROFESSIONAL USERS, INCLUDING A NEW SANDBOX AND TRAINING ENVIRONMENT \n\tENHANCED FUNCTIONALITY FOR ADMINISTRATIVE USERS TO MAKE SYSTEM-WIDE CONFIGURATION CHANGES AND EXPEDITIOUSLY ACCESS CRITICAL INFORMATION ABOUT THE STATUS OF DATA, USERS, AND OTHER COMMONLY REQUESTED INFORMATION\n\tNEW ACCOUNT MANAGEMENT HIERARCHY FEATURES THAT REDUCE THE BURDEN OF MANAGING DELEGATE AND MEDICAL COORDINATOR RELATIONSHIPS WITHIN AN ORGANIZATION\n\n\nTHE GOALS OF THE ENHANCEMENTS ARE THREEFOLD: \n\n\n\tCREATE AND ENHANCE SELF-SERVICE FEATURES THAT ALLOW MORE THOROUGH TESTING BY DATA SUBMITTERS AND ALLEVIATE ADMINISTRATIVE BURDEN ON BUSY HEALTHCARE PROFESSIONALS AND LAW ENFORCEMENT USERS\n\tIMPROVE DATA QUALITY AND SECURITY BY SUPPORTING DATA SUBMITTERS WITH A TESTING ENVIRONMENT AND THROUGH IMPROVEMENTS TO THE PDMP ADMINISTRATIVE TOOL\n\tINCREASE AWARENESS AND USE OF ENHANCED FEATURES THROUGH THE TUTORIAL ENVIRONMENT AND REFRESHED TRAINING MATERIALS ON THE WI EPDMP WEBSITE\n\n\nTO ACHIEVE THESE GOALS, DSPS INTENDS TO UTILIZE THE COLLABORATIVE PROCESS AND SERVICES OF NIC WISCONSIN (NIC) FOR THE TECHNICAL REQUIREMENTS OF THE PROJECT. DSPS HAS WORKED IN PARTNERSHIP WITH NIC, AS PART OF THE STATE\u2019S LARGER EGOVERNMENT PROGRAM, TO CREATE THE EPDMP SYSTEM IN 2015-17 AND CONTINUES TO PARTNER WITH THEM ON ALL ASPECTS OF THE EPDMP SYSTEM.\n\nTO EVALUATE THE SUCCESS OF THE PROJECT, DSPS WILL MEASURE THE NUMBER OF USERS INTERACTING WITH SELF-SERVICE FEATURES AND BEING SERVICED BY NEW ADMINISTRATIVE SYSTEM ROLES, THE NUMBER OF SUPPORT TICKET HOURS RELATED TO THE ISSUES ADDRESSED BY THE SELF-SERVICE FEATURES, AND THE SATISFACTION OF USERS INTERACTING WITH THESE NEW FEATURES. THE ULTIMATE GOAL OF THE PROJECT IS TO FURTHER THE EFFICACY OF THE WI EPDMP SYSTEM AND EXPAND ITS USEFULNESS IN WI\u2019S PRESCRIPTION DRUG MISUSE PREVENTION STRATEGY.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_15PBJA22GK03116PDMP_1550"}, {"internal_id": 154168648, "Award ID": "15PBJA22GK03115PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "THE DRUG OVERDOSE EPIDEMIC IS RAPIDLY EVOLVING IN TENNESSEE (TN). OPIOID PRESCRIBING FOR PAIN DECREASED BY 32% IN THE LAST FIVE YEARS (2017-2021). TN\u2019S CONTROLLED SUBSTANCE MONITORING DATABASE (CSMD) HAS BEEN A CRITICAL TOOL IN THIS FIGHT. DESPITE LOWER PRESCRIBING, TRENDS REFLECT A SHIFT FROM AN EPIDEMIC LARGELY DRIVEN BY PRESCRIPTION PAIN RELIEVERS TO ONE THAT INCLUDES ILLICIT OPIOIDS AND STIMULANTS. \n\nTO CONTINUE THE PROGRESS TN HAS MADE IN TRACKING DRUG OVERDOSE AND PRESCRIPTION MISUSE AND ABUSE IN OUR STATE, TDH PLANS TO CARRY OUT FOUR ACTIVITIES DURING THE THREE YEAR GRANT PERIOD: 1.) CONTINUE RXCHECK INTERSTATE DATA SHARING ONBOARDING AND PILOT AN ADDITIONAL FACILITY FOR CSMD ELECTRONIC HEALTH RECORDS (EHR) INTEGRATION; 2.) PROVIDE SUPPORT FOR THE HOSTING AND MAINTENANCE OF THE ENHANCED APPLICATION FOR SUBMISSION OF CONTROLLED DRUG SHIPMENT DATA\u00a0\u00a0 3.)\u00a0 DEVELOP AN IN-DEPTH EDUCATION PROGRAM FOR CSMD SYSTEM USERS; AND 4.) ENHANCE PUBLIC HEALTH AND PUBLIC SAFETY PARTNERSHIP TO BUILD A FRAMEWORK FOR INFORMATION SHARING TO ADDRESS THE DRUG OVERDOSE EPIDEMIC.\n\nTHE CSMD HAS BEEN A KEY TOOL IN TN\u2019S STEADY DECLINE IN OPIOID PRESCRIBING. THE FIRST GRANT ACTIVITY INCLUDES EXPANDING OPTIONS FOR QUERYING INTERSTATE DATA USING RXCHECK, AND BETTER INTEGRATING THE CSMD INTO EHR UTILIZING RXCHECK. THESE EFFORTS WILL EXPAND CSMD ACCESS AND ENHANCE PROVIDER WORKFLOWS, SO THEY ARE ABLE TO MAKE BETTER CLINICAL DECISIONS. \n\nTHE SECOND ACTIVITY WILL PROVIDE SUPPORT TO THE HOSTING AND MAINTENANCE OF THE DRUG SHIPMENT DATA APPLICATION. THE PREVIOUS SYSTEM WAS APPROACHING END OF LIFE, AND THE NEW APPLICATION WILL IMPROVE DATA USED FOR SURVEILLANCE AND TRACKING OF SHIPMENT OUTLIERS TO PREVENT AND INVESTIGATE INAPPROPRIATE DRUG ORDERS.\n\nTHE THIRD ACTIVITY WILL DEVELOP AN IN-DEPTH EDUCATION PROGRAM FOR SYSTEM USERS. THE CSMD EDUCATIONAL PROGRAM WAS IN A STATE OF DORMANCY, THE PLAN IS TO REVITALIZE THE CSMD EDUCATION PROGRAM. A RESOURCE HUB OF TRAINING TUTORIALS, PRESENTATIONS, AND BOOKLETS WILL BE DEVELOPED AND MADE AVAILABLE TO ALL CSMD SYSTEM USERS TO PROVIDE INSTRUCTIONAL TUTORIAL VIDEO TRAININGS. \n\nTHE FOURTH ACTIVITY WILL ENHANCE A PUBLIC HEALTH AND PUBLIC SAFETY PARTNERSHIP TO BUILD A FRAMEWORK FOR INFORMATION SHARING. THIS PARTNERSHIP WILL BUILD ON THE EXISTING RELATIONSHIP TDH CURRENTLY HAS WITH THE TENNESSEE BUREAU OF INVESTIGATION (TBI) AS WE EXPAND AND INCLUDE ADDITIONAL PUBLIC SAFETY AGENCIES. THIS ADDITIONAL INFORMATION WILL BE VALUABLE AS WE CREATE A DATA INFRASTRUCTURE THAT CAN RAPIDLY IDENTIFY CHANGING TRENDS IN THE DRUG OVERDOSE EPIDEMIC AND PROVIDE DATA TO KEY STAKEHOLDERS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "63be0e77-930e-4b89-e9e3-610349642b13-C", "generated_internal_id": "ASST_NON_15PBJA22GK03115PDMP_1550"}, {"internal_id": 154167172, "Award ID": "15PBJA22GK03114PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "IMPROVING PRESCRIPTION DRUG MONITORING (PDMP) USE AND THE SAFETY OF CONTROLLED MEDICATION PRESCRIBING IS A PILLAR OF THE NATIONAL RESPONSE TO THE WORSENING OPIOID CRISIS. A STATED PURPOSE OF THE FUNDING IS TO ENHANCE THE CAPACITY OF PUBLIC HEALTH OFFICIALS TO COLLECT AND ANALYZE CONTROLLED SUBSTANCE PRESCRIPTION DATA, STRENGTHENING STATES\u2019 ABILITY TO ENHANCE PDMPS BY ACCOMMODATING LOCAL DECISION-MAKING AND ENCOURAGING PROMISING PRACTICES. THE EVIDENCE BASE FOR PDMPS WOULD BENEFIT GREATLY FROM RESEARCH PRODUCING HIGH QUALITY, ACTIONABLE DATA LINKING AND MEASURING PDMP USE AND IMPORTANT PATIENT OUTCOMES. DATA SILOS COMMONLY LIMIT THE MEASUREMENT OF PDMP UTILIZATION AND THE LINKAGE OF PDMP USE TO PROVIDER PRESCRIBING ACTIONS. BEST PRACTICE DATA LINKAGE STRATEGIES CAN FACILITATE A ROBUST EVALUATION OF PDMP EFFECTIVENESS AND, SPECIFICALLY, THE IMPACT OF COLORADO\u2019S NEW PDMP REGULATIONS WHICH MANDATE PDMP CHECKS PRIOR TO OPIOID AND BENZODIAZEPINE PRESCRIPTIONS WITH CERTAIN EXCEPTIONS. \n\nTHE OBJECTIVE OF THIS PROJECT IS TO IMPROVE DATA ARCHITECTURE ACROSS COLORADO\u2019S LARGEST HOSPITAL SYSTEM TO EFFECTIVELY MEASURE CLINICIAN PDMP USE TO ADDRESS GAPS DATA, COMPLIANCE WITH STATUTES, AND IMPORTANT OUTCOMES ASSOCIATED WITH NEW PDMP REGULATIONS. BY FACILITATING ROBUST EVALUATIONS OF PROCESS (E.G., PDMP USE, OPIOID PRESCRIBING) AND PATIENT OUTCOMES (E.G., FUTURE OPIOID USE, CO-PRESCRIBING, DEATH), THIS DATA SYSTEM WILL EXPEDITE THE MEASUREMENT OF PDMP EFFECTIVENESS ON CHANGING OPIOID PRESCRIBING. FURTHER, EVALUATION OF CLINICAL DECISION SUPPORT (CDS) TO PROMOTE COMPLIANCE WITH REGULATION CAN DETERMINE IF MANDATES RESULT IN INCREASED PDMP USE, DECREASED OPIOID EXPOSURES, HIGH-RISK PRESCRIPTIONS, MORBIDITY, AND MORTALITY. THIS PROJECT WILL ENHANCE THE PDMP IN THREE KEY WAYS:\n\n\n\tADDRESS INEFFICIENCIES OF COLLECTING PDMP USE DATA. IMPROVED COLLECTION OF PDMP DATA AT THE PATIENT VISIT LEVEL WILL ALLOW FOR RAPID ANALYSIS OF PDMP USE AND INTERVENTIONS.\n\tIMPLEMENT EFFECTIVE PDMP INTERVENTIONS. PDMP CDS TOOLS CAN ACCELERATE THE UPTAKE OF MANDATED PDMP ACTIONS WHILE ROUTINE DATA COLLECTION CAN BE USED TO ASSESS OUTCOMES.\n\tADDRESS SUSTAINABILITY. HEALTH SYSTEM WIDE IMPLEMENTATION WILL STRENGTHEN CAPACITY TO RAPIDLY EVALUATE THE EFFECTIVENESS OF MULTIPLE NEW PDMP POLICY INTERVENTIONS.\n\n\nTHE PROPOSED PROJECT WILL ACHIEVE THIS USING A SINGLE SYSTEM, PRAGMATIC, CLUSTER RANDOMIZED TRIAL OF CDS TO DELIVER NEW STATE MANDATED PDMP REGULATIONS COMPARED TO USUAL CARE TO EVALUATE: PDMP USE, REGULATORY COMPLIANCE, AND ASSOCIATED PATIENT OUTCOMES. THIS WILL BE PERFORMED ACROSS THE UCHEALTH SYSTEM IN COLLABORATION WITH COLORADO DEPARTMENT OF REGULATORY AGENCIES (DORA) TO MAXIMIZE THE QUALITY AND IMPACT OF THE WORK AND GENERATE NOVEL, GENERALIZABLE KNOWLEDGE TO SUPPORT THE PROGRESS OF PDMPS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "04c91383-4791-7851-87fe-3cebca9b8ce1-C", "generated_internal_id": "ASST_NON_15PBJA22GK03114PDMP_1550"}, {"internal_id": 154165134, "Award ID": "15PBJA22GK03113PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "PROJECT ABSTRACT\n\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FUNDING IS REQUESTED FOR THE BUREAU OF JUSTICE ASSISTANCE HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP) FISCAL YEAR 2022 COMPETITIVE GRANT. THIS FUNDING REQUEST IS FOR $1,400,000 FOR 3 YEARS BEGINNING OCTOBER 1, 2022, AND ENDING SEPTEMBER\u00a030, 2025.\n\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0THE ALABAMA (AL) DEPARTMENT OF PUBLIC HEALTH (ADPH) IS REQUESTING TO FUND THE AL PDMP ACTIVITIES AND ENHANCEMENTS WITH THE PRIMARY GOAL OF REDUCING AND DETECTING PRESCRIPTION DRUG DIVERSION AND ABUSE. THIS GOAL WILL BE OBTAINED BY MEETING THE FOLLOWING OBJECTIVES: (1)\u00a0ENHANCE PDMP; (2)\u00a0MAINTAIN INTERSTATE DATA SHARING AND ELECTRONIC HEALTH RECORD AND PHARMACY MANAGEMENT SOFTWARE INTEGRATION; (3) IMPROVE THE QUALITY AND ACCURACY OF PDMP DATA; (4) PROVIDE TRAINING FOR PDMP USERS; AND (5) PROVIDE SUBSTANCE USE EDUCATION AND SUPPORT COLLABORATIONS WITH STAKEHOLDERS.\n\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0AL PDMP WILL CONTINUE PARTNERING WITH REGULATORY BOARDS, THE AUBURN UNIVERSITY HARRISON COLLEGE OF PHARMACY, HEALTHCARE PROFESSIONAL ORGANIZATIONS, AND OTHERS.\n\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0THE ACTIVITIES OF THIS GRANT OPPORTUNITY WILL SERVICE ALL AL PDMP USERS LOCATED THROUGHOUT AL. THE COMPLIANCE PROGRAM WILL EDUCATE DISPENSERS TO ENSURE INTEGRITY OF PDMP DATA, AND THE EDUCATIONAL SUMMIT WILL REACH AN INTERDISCIPLINARY TEAM OF HEALTHCARE PROVIDERS, LAW ENFORCEMENT, ADDICTION TREATMENT STAFF, SOCIAL WORKERS, AND THE PUBLIC. \n\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 WITH THIS FUNDING OPPORTUNITY, AL PDMP WILL CONTINUE TO PROVIDE A PLATFORM FOR PRESCRIBERS AND DISPENSERS TO OBTAIN VITAL INFORMATION FOR THE APPROPRIATE PRESCRIBING AND DISPENSING OF CONTROLLED SUBSTANCES. THE INFORMATION PROVIDED WILL HAVE A DIRECT IMPACT ON THE CITIZENS OF AL BY REDUCING AND DETECTING PRESCRIPTION DRUG DIVERSION AND ABUSE, WHICH WILL CONTINUE TO BE A SOLUTION TO THE OPIOID CRISIS IN AL.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ca11d49a-d5d1-6d25-24ad-88bc4bad9829-C", "generated_internal_id": "ASST_NON_15PBJA22GK03113PDMP_1550"}, {"internal_id": 154167666, "Award ID": "15PBJA22GK03112PDMP", "Award Amount": 1400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-27", "CFDA Number": "16.754", "Description": "THIS PROPOSAL IS FOR FUNDING TO SUPPORT THE IMPLEMENTATION OF MISSOURI\u2019S FIRST STATEWIDE PRESCRIPTION DRUG MONITORING PROGRAM (PDMP). \n\nTHE JOINT OVERSIGHT TASK FORCE FOR PRESCRIPTION DRUG MONITORING (JOTF) CREATED THROUGH SENATE BILL 63, WILL SELECT A PDMP VENDOR THROUGH A COMPETITIVE BID PROCESS.\u00a0 ONCE SELECTED, THE JOTF WILL UTILIZE FUNDING FROM THIS GRANT TO TRAIN/EDUCATE PRESCRIBERS AND DISPENSERS THROUGHOUT THE STATE ON THE PROCESSES INVOLVED TO SUBMIT DATA AND BE COMPLIANT WITH MISSOURI LAW. THIS WILL REQUIRE NUMEROUS COMMUNICATION STRATEGIES INCLUDING ONLINE TRAINING OPPORTUNITIES, WEBINARS AND TRAVEL TO IN-PERSON EVENTS TO ENSURE FAMILIARITY AND KNOWLEDGE OF THE SYSTEM AND THE STATE REQUIREMENTS. \u00a0TECHNICAL ASSISTANCE TO ENSURE ACCESS TO THE PDMP WILL ALSO BE A COMPONENT OF THIS GRANT-FUNDED OUTREACH. \n\nTHE STATEWIDE PDMP WILL BENEFIT ALL MISSOURIANS. PATIENTS WILL BENEFIT THROUGH THE KNOWLEDGE GAINED BY PRESCRIBERS THAT UTILIZE THE PDMP PRIOR TO MAKING PRESCRIPTIVE DECISIONS. \u00a0REVIEWING PDMP DATA WILL PREVENT LIFE-THREATENING CONTROLLED SUBSTANCE INTERACTIONS THAT POSE A RISK FOR PATIENTS UTILIZING MORE THAN ONE PROVIDER.\u00a0 PDMP DATA WILL IDENTIFY AT-RISK PATIENTS AND ALLOW PRESCRIBERS TO REFER INDIVIDUALS FOR TREATMENT. PROVIDERS WILL BENEFIT BY HAVING ACCESS TO A GREATER VIEW OF THE ACTIVE CONTROLLED SUBSTANCE PRESCRIPTIONS ON FILE FOR A PATIENT. THE AVAILABILITY OF CONTROLLED SUBSTANCE INFORMATION AS AN ADDITIONAL TOOL ALLOWS PRESCRIBERS TO SAFELY DELIVER EFFECTIVE TREATMENT WHILE ALSO INCREASING CONFIDENCE IN THEIR PRESCRIBING DECISIONS. PHARMACISTS BENEFIT FROM PDMP DATA BY PROVIDING INFORMATION TO HELP ENSURE PATIENTS HAVE ACCESS TO ESSENTIAL MEDICATIONS. PDMP DATA WILL ALLOW PHARMACISTS TO IDENTIFY CANDIDATES IN NEED OF ADDITIONAL PHARMACIST-INITIATED COUNSELING OR TO INITIATE A CONVERSATION WITH A PROVIDER WHEN QUESTIONABLE PRESCRIBING PATTERNS ARE REALIZED. PDMP DATA USED APPROPRIATELY BY PRESCRIBERS AND DISPENSERS AIDS LAW ENFORCEMENT.\u00a0 THIS BENEFIT IS REALIZED WHEN THERE IS A REDUCTION IN THE NUMBER OF CONTROLLED SUBSTANCE PRESCRIPTIONS LEADING TO FEWER OPPORTUNITIES FOR DIVERSION, MISUSE OR OVERDOSE.\u00a0 \n\nOVERALL, THE MOST ANTICIPATED OUTCOME FROM THE STATEWIDE PDMP WILL BE THE REDUCTION IN DEATHS FROM MISUSE OF CONTROLLED SUBSTANCES.\u00a0 DATA REPORTS WILL ALLOW PROVIDERS TO MORE FULLY UNDERSTAND THEIR PRESCRIBING HABITS AND OFFER OPPORTUNITIES FOR COMPARISON WITH PEERS.\u00a0 DISPENSERS WILL IDENTIFY OPPORTUNITIES TO ASSIST OR EDUCATE PATIENTS/PRESCRIBERS AND THEY WILL HAVE THE ABILITY TO STOP THE DISPENSING OF AN UNSAFE PRESCRIPTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2dcf441-68c7-4ce9-b59e-96b06fa121a5-C", "generated_internal_id": "ASST_NON_15PBJA22GK03112PDMP_1550"}, {"internal_id": 154166395, "Award ID": "15PBJA22GG03585PDMP", "Award Amount": 6080000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2022-09-29", "CFDA Number": "16.754", "Description": "IIR PROPOSES TO CONTINUE TO SUPPORT THE CRITICAL WORK OF THE HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP) TRAINING AND TECHNICAL ASSISTANCE (TTA) PROGRAM THROUGH ITS PDMP TTA CENTER (TTAC) TEAM. THE TTAC TEAM HAS SUPPORTED BJA AND THE PDMP COMMUNITY FOR MORE THAN A DECADE, FACILITATING THE SHARING OF NEW INITIATIVES AND INNOVATIONS AMONG PDMPS AND DISSEMINATING PROVEN, EVIDENCE-BASED, AND EFFECTIVE PRACTICES. BUILDING ON ITS WORK OVER THE PAST 12 YEARS, THE TTAC TEAM WILL CONTINUE TO PROVIDE RESOURCES TO AND COORDINATE INFORMATION SHARING AMONG PDMPS AND OTHER STAKEHOLDERS AND WILL COLLABORATE WITH NATIONAL ORGANIZATIONS, FEDERAL AND STATE AGENCIES, AND OTHER EXPERTS TO PROVIDE THE HIGHEST-QUALITY TTA SERVICE TO BJA GRANTEES, PDMP ADMINISTRATORS, AND OTHER STAKEHOLDERS IN CARRYING OUT THE PROGRAM REQUIREMENTS AND DELIVERABLES.\n\nIN COORDINATION WITH BJA, IIR\u2019S TTAC TEAM WILL ASSIST PDMP COMMUNITIES TO PLAN, IMPLEMENT, SUSTAIN, AND ENHANCE THEIR PROGRAMS THROUGH THE EXCHANGE OF INFORMATION AND THE COLLECTION OF DATA AND WILL ALSO WORK TO INCREASE COLLABORATION AMONG LAW ENFORCEMENT, PROSECUTORS, PUBLIC HEALTH OFFICIALS, TREATMENT PROVIDERS, AND/OR DRUG COURTS THROUGH THE STATE PDMPS. THE TTAC TEAM WILL CONTINUE ITS EFFORTS TO ENSURE THE QUALITY AND ACCURACY OF PDMP DATA LOCALLY, REGIONALLY, AND NATIONALLY TO INCREASE THE USE OF PRESCRIBERS AND THE UTILITY TO PRESCRIBERS AND WILL CONTINUE TO SUPPORT THE RXCHECK HUB AS A FULLY OPERATIONAL DATA SHARING SYSTEM TO SECURELY AND EFFICIENTLY SHARE PDMP DATA BETWEEN STATES OR WITH A HEALTH INFORMATION EXCHANGE/ELECTRONIC HEALTH RECORD (HIE/EHR) SYSTEM.\n\nTHE HAROLD ROGERS PDMP TTA PROGRAM PLAYS A KEY ROLE IN COMBATING THE PRESCRIPTION DRUG EPIDEMIC IN THE UNITED STATES, AND THE TTAC TEAM\u2019S MECHANISMS FOR PDMPS TO COMMUNICATE, SHARE PROMISING PRACTICES, AND ACCESS VALUABLE TOOLS AND RESOURCES ARE FUNDAMENTAL UNDERPINNINGS OF THE PROGRAM\u2019S SUCCESS. IIR, ITS TTAC TEAM, AND IIR\u2019S PARTNER, THE IJIS INSTITUTE, LOOK FORWARD TO MEETING THE GOAL OF THE HAROLD ROGERS PDMP TTA PROGRAM BY SERVING AS A NATIONAL RESOURCE FOR PDMP GRANTEES AND OTHER STAKEHOLDERS; CONDUCTING PDMP ASSESSMENTS AND REVIEWING LEGISLATION; PROVIDING SUBJECT-MATTER EXPERTISE FOR MEETINGS; DEVELOPING ARTICLES, WEBINARS, AND PODCASTS; FACILITATING COMMUNICATION AND PEER-TO-PEER INFORMATION SHARING; SUPPORTING NATIONAL AND FEDERAL PARTNERS; AND SUPPORTING THE RXCHECK HUB.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7fa6e978-fa6f-3498-fedb-fd43149fe3ce-C", "generated_internal_id": "ASST_NON_15PBJA22GG03585PDMP_1550"}, {"internal_id": 146120351, "Award ID": "15PBJA21GG03351PDMP", "Award Amount": 1650000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-15", "CFDA Number": "16.754", "Description": "ILLINOIS 2021 PRESCRIPTION MONITORING PROGRAM ENHANCEMENT PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "76cf737b-6066-d86b-2865-0295d98359df-C", "generated_internal_id": "ASST_NON_15PBJA21GG03351PDMP_1550"}, {"internal_id": 146121413, "Award ID": "15PBJA21GG02615PDMP", "Award Amount": 1768360.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "MODERNIZATION OF REPORTING FOR CALIFORNIA PDMP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "87af3ad1-955d-6282-9592-3ae0bf29dc15-C", "generated_internal_id": "ASST_NON_15PBJA21GG02615PDMP_1550"}, {"internal_id": 146121336, "Award ID": "15PBJA21GG02614PDMP", "Award Amount": 1600000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-15", "CFDA Number": "16.754", "Description": "MAINE PRESCRIPTION MONITORING PROGRAM (PMP) ENHANCED PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1cf12f71-770d-5b35-7c1a-137151b613b1-C", "generated_internal_id": "ASST_NON_15PBJA21GG02614PDMP_1550"}, {"internal_id": 146122822, "Award ID": "15PBJA21GG02613PDMP", "Award Amount": 1084886.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "GUAM PDMP DATA ENHANCEMENT TO UPDATE RULES & REGULATIONS TO INCLUDE PRESCRIBER REPORT CARDS, MANDATORY REGISTRATION, AND MANDATORY USE COMPLIANCE MODULE..", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GU", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "24e6ad11-f067-66f7-95be-c2e992c17f54-C", "generated_internal_id": "ASST_NON_15PBJA21GG02613PDMP_1550"}, {"internal_id": 146122363, "Award ID": "15PBJA21GG02612PDMP", "Award Amount": 1650000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "OKLAHOMA PMP INTEGRATION WITH PRESCRIBER WORKFLOW", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0f7f672e-1cc8-1e61-1451-a9cb548d3a6e-C", "generated_internal_id": "ASST_NON_15PBJA21GG02612PDMP_1550"}, {"internal_id": 146121559, "Award ID": "15PBJA21GG02611PDMP", "Award Amount": 1650000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "ENHANCING THE FUNCTIONALITY OF PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ca11d49a-d5d1-6d25-24ad-88bc4bad9829-C", "generated_internal_id": "ASST_NON_15PBJA21GG02611PDMP_1550"}, {"internal_id": 146122684, "Award ID": "15PBJA21GG02610PDMP", "Award Amount": 1399678.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "KASPER SYSTEM ENHANCEMENTS FOR EFFICIENT UTILIZATION OF DATA USE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f3240e4-fc98-a5c7-822a-25e57f9d8ec3-C", "generated_internal_id": "ASST_NON_15PBJA21GG02610PDMP_1550"}, {"internal_id": 146120522, "Award ID": "15PBJA21GG02609PDMP", "Award Amount": 1572550.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "SOUTH DAKOTA PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5977c26b-55c9-a9b6-4eae-6ac7c2655500-C", "generated_internal_id": "ASST_NON_15PBJA21GG02609PDMP_1550"}, {"internal_id": 146121674, "Award ID": "15PBJA21GG02608PDMP", "Award Amount": 1648239.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "BJA FY 21 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "029201fb-3584-d3e8-463e-e1d59e975a9c-C", "generated_internal_id": "ASST_NON_15PBJA21GG02608PDMP_1550"}, {"internal_id": 146121384, "Award ID": "15PBJA21GG02607PDMP", "Award Amount": 1627287.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "ENHANCING ACCESS TO E-FORCSE DATA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "31a5b8d3-9079-b062-f46b-9178c5e6c477-C", "generated_internal_id": "ASST_NON_15PBJA21GG02607PDMP_1550"}, {"internal_id": 146121867, "Award ID": "15PBJA21GG02605PDMP", "Award Amount": 1558436.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "THE MINNESOTA PRESCRIPTION MONITORING PROGRAM- SIMPLIFYING ACCESS AND IMPROVING QUALITY OF DATA TO AUTHORIZED ACCOUNT HOLDERS AND EXPANDING SECURE ACCESS ACROSS BORDERS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3e8aa2fc-52a7-d9fc-8c89-c15ca0f3fb64-C", "generated_internal_id": "ASST_NON_15PBJA21GG02605PDMP_1550"}, {"internal_id": 146122403, "Award ID": "15PBJA21GG02604PDMP", "Award Amount": 1648500.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "EXPANDING WI EPDMP ACCESS AND INTEGRATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c46f90-91a5-e937-6c2b-331f37528922-C", "generated_internal_id": "ASST_NON_15PBJA21GG02604PDMP_1550"}, {"internal_id": 146121933, "Award ID": "15PBJA21GG02603PDMP", "Award Amount": 1650000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "BJA FY 21 HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM(PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1f35f133-3ae9-023d-1209-13dcedc4ca06-C", "generated_internal_id": "ASST_NON_15PBJA21GG02603PDMP_1550"}, {"internal_id": 146122668, "Award ID": "15PBJA21GG02602PDMP", "Award Amount": 1648958.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "OPTIMIZING MARYLAND'S PRESCRIPTION DRUG MONITORING PROGRAM (PDMP)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3c30f51b-0198-c278-4848-50104ea4824f-C", "generated_internal_id": "ASST_NON_15PBJA21GG02602PDMP_1550"}, {"internal_id": 146121922, "Award ID": "15PBJA21GG02601PDMP", "Award Amount": 1648455.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-10-21", "CFDA Number": "16.754", "Description": "OHIO AUTOMATED RX REPORTING SYSTEM (OARRS) FY 2021 DATA ENHANCEMENT AND INTEGRATION PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f90d95d1-cf68-ff64-d637-48c86f5103dc-C", "generated_internal_id": "ASST_NON_15PBJA21GG02601PDMP_1550"}, {"internal_id": 146967460, "Award ID": "15PBJA21GG02600PDMP", "Award Amount": 1171200.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-11-10", "CFDA Number": "16.754", "Description": "PUERTO RICO PRESCRIPTION DRUG MONITORING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ccec1439-4fc7-aa7b-66d5-8ed9ab9f57bb-C", "generated_internal_id": "ASST_NON_15PBJA21GG02600PDMP_1550"}]